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Abstract
The goal of this research is to identify compounds which act as inhibitors for the 
synthesis of guanosine 5’-diphospho-L-&cose (GDP-fiicose). The enzymes involved in this 
pathway are guanosine 5 ’-diphospho-D-mannose 4,6-dehydratase (GDP-D-mannose 4,6- 
dehydratase) and guanosine 5 ’ -diphospho-4-keto-6-I>-deoxymannose epimerase/guanosine 
5 ’ -diphospho-4-keto-6-L-galactose reductase (also known as FX protein and GDP-fiicose 
synthetase). In this research project, GDP-mannose 4,6-dehydratse, the first enzyme in this 
pathway was studied. The plasmid DNA that contained the gene for GDP-mannose 4,6- 
dehydratase was transformed into £  coli bacteria; the enzyme was expressed and purified 
for use in this research. Before assaying the enzyme, a method of analysis for the products 
of the enzyme reaction had to be developed. This lead to the development of an HPLC 
method to analyze guanosine nucleotides and guanosine sugar nucleotides, which has not 
been previously described in the literature. Once the enzyme was purified and the assay 
developed, a study of the enzyme kinetics was initiated. The Km value for GDP-mannose 
4,6-dehydratse calculated in this research project was 280+12.3 /iM and the Vmax was 
determined to be 0.102+0.0008 pmoles/min. The potential inhibitor compounds were 
selected based on their structurally similarity to the intermediate of the enzyme reaction. 
GDP-4-keto-6-deoxymaimose, as well as the end product, GDP-fiicose. The compounds 
that have shown a significant inhibitory effect on GDP-mannose 4,6-dehydratase include 
GDP-fucose, 1 -deoxyfuconojirimycin, GDP, fiicose, 1 -deoxymaimojirimycin, and 1- 
deoxynojirimycin. Several compounds were screened that did not show a detectable effect 
on the GDP-mannose 4,6-dehydratase enzyme. These included UDP-galactose, UDP- 
glucose, ADP-ribose, and tunicamycin.
xv
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Chapter 1 
Introduction
1.1 Goals and Aims of Research
The overall goal of this research project is to develop an enzyme inhibitor that 
will impede the inflammation process. This will be achieved by interrupting the 
pathway responsible for synthesis of guanosine 5’-diphospho-L-fucose (GDP-fiicose). 
The enzymes involved in this pathway are guanosine 5'-diphospho-D-mannose 4,6- 
dehydratase (GDP-mannose 4,6-dehydratase) and guanosine 5’-diphospho-4-keto-6-D- 
deoxymannose epimerase/ guanosine S’-diphosph-4-keto-6-L-galactose reductase (also 
known as FX protein).1’2 Because this pathway produces fiicose, which is important in 
the inflammation process, inhibition of this sequence of reactions can have important 
pharmaceutical implications.
In this project, the first enzyme in the enzymatic synthesis of fucose, GDP- 
mannose 4,6-dehydratrase, has been studied as an essential first step in attaining the 
overall goal of this research. This enzyme is responsible for conversion of GDP- 
mannose into GDP-4-keto-6-deoxymannose This product is used as the substrate for 
the second enzyme, the FX protein. If the catalysis caused by this enzyme can be 
slowed or stopped, then the synthesis of GDP-fiicose will be affected and consequently 
so will the inflammation process.
Several specific aims were defined to meet the goal of this research project. The 
first of these objectives is to transfect bacteria cells with plasmid DNA that contains the 
gene for the GDP-mannose 4,6-dehydratase enzyme. After transformation the bacteria
1
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can be used to produce the enzyme, which must be purified before it can be used to in 
an enzyme assay studying inhibitors.
A second aim of this project is to develop an assay for detection of the products 
resulting from the enzyme assay. In the literature a few papers describe high 
performance liquid chromatography (HPLC) separation of uridine sugar nucleotides and 
uridine nucleotides.3̂  These methods were tried but were unsuccessful at separating the 
guanosine nucleotides used in this research. This HPLC method that was developed is 
very important, not only in this research project, but also in general for other research 
which involves the separation of guanosine based nucleotides.
Choosing molecules to screen as potential inhibitors was the third aim of this 
project. These molecules were chosen based on their structural similarities to the 
substrates, intermediates, or products involved in this enzyme pathway. As part of this 
research, we tried to define a structure-activity relationship for this enzyme. In doing 
this it is important to carefully study the structures of molecules that are selected and 
determine the information that can be gained from studying the GDP-mannose 4,6- 
dehydratase enzyme with those molecules.
The final aim of this research project is to study the enzyme kinetics for GDP- 
mannose 4,6-dehydratase. This will first be performed without potential inhibitors 
present, and then with the selected inhibitor molecules in the enzyme assay reaction 
mixture. It is hoped that by examining the kinetics of this enzyme with various 
potential inhibitor molecules present information concerning the structure of an 
effective inhibitor can be established. This is the beginning to establishing a structure- 
activity relationship for GDP-mannose 4,6-dehydratase.
2
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1.2 Research Synopsis
The first step in this research project as described above of was transformation 
of bacteria cells into competent cells with the plasmid DNA containing the gene for the 
GDP-mannose 4,6-dehydratase enzyme. This was accomplished by following standard 
electroporation procedures.7 Bacteria cells were exposed to an electric field, causing 
small, transient, openings to form in their cell walls allowing the plasmid DNA to 
diffuse into the cells. The cells were grown and the plasmid DNA isolated from the 
new competent cells. This plasmid DNA was analyzed using restriction enzyme digests 
followed by agarose gel electrophoresis.
Once it was confirmed that the plasmid DNA had been transfected into the 
bacteria cells, the enzyme was over-expressed in these cells. The GDP-mannose 4,6- 
dehydratase was isolated and purified for use in assays to study the kinetics of the 
conversion of GDP-mannose to GDP-4-keto-6-deoxymannose. The enzyme was 
purified using a series of ion-exchange chromatography columns including 
diethyiaminoethyl (DEAE) and hyrdoxyapathe (HA). As the enzyme was eluted from 
these purification columns, fractions were collected and then analyzed for their UV 
absorption at 280 nm. This indicated which fractions contain protein and need to be 
analyzed further. Analysis by polyacrylamide gel electrophoresis (PAGE) to determine 
the molecular weight of the proteins eluted from the ion-exchange columns was 
performed and the proteins with the correct molecular weight of approximately 40 kD 
were analyzed for enzyme activity. Fractions that exhibited the ability to convert GDP- 
mannose to GDP-4-keto-6-deoxymannose were then stored at 4°C until kinetic analyses 
were performed.
3
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Next, it was necessary to develop an HPLC method to analyze the guanosine 
sugar nucleotides and nucleotides formed in this enzyme reaction. Methods described 
in the literature were designed to separate uridine nucleotides.3"6 When these methods 
were tested using guanosine sugar nucleotides, resolution of the guanosine nucleotides 
and sugar nucleotides was very poor. The starting point for developing a method that 
had high resolution for these guanosine-based compounds was phosphate buffer with a 
pH approximately 4. This was the common thread through each of the methods test that 
gave poor resolution of the guanosine analytes. Mobile phase modifiers such as 
acetonitrile and methanol were added to the mobile phase, but this seemed to have no 
improvement on the resolution of the analytes. Next, the phosphate buffer 
concentration was adjusted and again this was unsuccessful at improving the resolution. 
Finally, what seemed to have the most effect on the resolution was changing the mobile 
phase pH. This was achieved by titrating a 0.5 M dibasic phosphate buffer and 0.5 M 
monobasic phosphate buffer together until the desired pH was obtained. This 
separation appears to be extremely pH sensitive. Changing the pH from 6.1 to 6.2 to
6.3 causes the peaks to co-elute then to completely resolve and then to co-elute again. 
This drastic change in resolution with a slight change in the pH of the buffer is because 
at pH 6.2, the mobile phase is just between the pKa values for these analytes causing 
them to be interact differently with the octadecyl stationary phase and therefore elute 
independently from the column.8 This method developed to resolve the standard 
compounds guanosine 5’-diphosphate (GDP), guanosine 5’-monophosphate (GMP), 
GDP-mannose, and GDP-fiicose was then used to separate the products from the
4
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enzyme assay. This separation was successful and the HPLC method developed in this 
work was used for all the enzyme assays conducted.
After a working analysis method was established, kinetics of the system was 
studied. First an enzyme assay was conducted using standard reaction conditions as 
indicated by many researchers in the field.9 These kinetic parameters KM, the Michaels 
Menten constant, and Vmax, the maximum velocity for the reaction, were established 
for the purified GDP-mannose 4,6-dehydratase. The Km for this enzyme under these 
reaction conditions was calculated to be 283.3+12.3 /iM and the Vmax was 0.102+ 
0.0008 /iM/min. This Km value is in agreement with the work of previous researchers 
studying this enzyme using similar reaction conditions. The Vmax values differ from 
that reported by other workers. This is believed to be due to the purity of the enzyme 
used in the experiments performed in this work. Next the enzyme kinetics were studied 
with various potential inhibitor molecules present. The potential inhibitor molecules 
were selected on the basis of the similarity of structure to the ones involved in the 
enzyme pathway. The molecules selected for screening against the GDP-mannose 4.6- 
dehydratase enzyme included GDP-fiicose, GDP, fiicose, 1-deoxymannojirimycin, 1- 
deoxyfuconojirimycin, 1-deoxynojirimycin, UDP-galactose, UDP-glucose, ADP-ribose, 
and tunicamycin. These inhibitor molecules were test at concentration levels of 2S0, 
1000, and 5000 pM. A compound was found to be inactive against this enzyme if no 
effect on the enzyme was observed at 5000 /iM or 5 mM. UDP-galactose, UDP- 
glucose, ADP-Ribose, and tunicamycin were found to be ineffective against GDP- 
mannose 4,6-dehydratase. Of the other compounds listed above, GDP-fiicose was 
found to be the best inhibitor with a Kj value of 95.4+1.85 fM . The structural moieties
5
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that make up GDP-fiicose, GDP and fucose, were then screened against the GDP- 
mannose 4,6-dehydratase enzyme. These compounds were also active against this 
enzyme. The next compounds that were screened include 1-deoxymannojirimycin, l- 
deoxyfuconojirimycin, and 1 -deoxynojirimycin. These molecules were selected 
because structurally they resemble the monosaccharides that make up the 
monosaccharide portion of the sugar nucleotides that are the substrate and product in 
this reaction. These molecules were also found to be active against this enzyme. 1- 
deoxyfuconojirimycin was the most effective inhibitor of the 1-deoxynojirimycin series 
with a Kj value of 337.9+12.8 f/M. The other molecules of this series were also 
effective against the GDP-mannose 4,6-dehydratase enzyme with K; values of 991+18.2 
and 1503+14.01 //M respectively.
1.3 Enzyme Reactions
Enzyme molecules were first recognized as early as 1835 by Jons Berzelius who 
is responsible for discovering several chemical elements, writing chemical symbols, and 
coining the term catalysis.9 He noted that potatoes contained a substance that catalyzed 
the breakdown of starch.
The chemical nature of enzyme reactions or catalysis remained unknown for 
many years until about 1850 when Louis Pastuer demonstrated that fermentation 
occurred in the presence of living cells and failed to occur once these cells were 
destroyed by heat. After several years of work, Arthur Harden and William Young 
showed that yeast extracts contained large nondialyzable molecules - enzymes - that 
were easily destroyed by heat and fermentation reactions did not occur without these 
molecules. Thus, these studies were the beginning of the of enzyme analysis.
6
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An enzyme is a large protein molecule that catalyzes a biological reaction by 
lowering the energy of activation for the reaction. Enzyme catalyzed reactions are 103 
to 1016 times faster than uncatalyzed reactions.10 The portion of the enzyme responsible 
for specificity in recognizing an analyte in the reaction is called the active site. This 
active site can be subdivided into the binding she which “holds” the substrate and the 
catalytic site where the catalysis or bond breaking actually occurs.
An enzyme reaction must meet the same three criteria that a chemical reaction 
must meet: 1. reactants, or substrates in enzyme reactions, must collide; 2. the collision 
of these molecules must occur with the correct orientation; and 3. reactants must have 
sufficient energy in order to overcome the energy of activation of the reactions. An 
enzyme works to increase the reaction rate by lowering the energy of activation, as well 
as promoting a higher probability that the reactants are in the correct orientation for a 
collision.
Leonor Michaelis and Maude Menten first described a general treatment for the 
kinetics of enzyme-catalyzed reactions in 1913.10 The object of this treatment was to 
relate the reaction rates of observable quantities and interpretable molecular parameters. 
This treatment assumed two ideas. First, the enzyme-substrate (ES) complex is in 
equilibrium with the free enzyme (E) and the substrate (S). Secondly, the formation of 
the product (P) only proceeds through the ES complex.
Equation 1.1 E + S <=> ES -> E + P
The slow step in the above equation is assumed to be the formation of E and P from the
ES complex.
7
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Another treatment for the derivation of equations that governs the catalytic 
activity of an enzyme assumes a steady-state condition. In this derivation, the rate 
constant of each step along the enzyme pathway was considered, as shown in Equation
1.2
Equation 1.2 E+ S <=> ES -> E + P
In this derivation, it is thought that the rate of conversion of ES to product (kz) is 
comparable to the rate of its dissociation (£.1), therefore, the rapid-equilibrium 
assumption of the first derivation of enzyme kinetic equations is not valid. Thus, this 
assumption of steady state kinetics has to be considered.
The steady-state assumption states that the concentration of ES complex will be 
small and constant provided that total enzyme, [E]t  < [S], The velocity of the enzyme 
reaction, v, can be expressed as shown below in Equation 1.3 
Equation 1.3 v = (kz [E],[S]) / (Km + [5])
where Km is the Michaelis-Menten term equal to (k.\ + kz) / k\. This Km term is an 
apparent dissociation constant that may be treated as the overall dissociation constant of 
all enzyme-bound species. 11 This Km value, as well as the maximum velocity (Vmax), 
can be calculated by graphically representing the data using a Lineweaver-Burk plot. 
This graph is constructed by plotting 1/v versus 1/[S]. The equation that this graph is 
based on is shown below as Equation 1.4 
Equation 1.4 1/v = (1/Vmax) + (K m /  Vmax[S])
The y-intercept is defined as 1/Vmax while the x-intercept is defined as - I / K m. The 
slope of this line is therefore Km / Vmax. These relationships are used to calculate the 
kinetic data for the enzyme system studied in this research.
8
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The type of inhibition exhibited by each of the potential inhibitors for the 
reaction at hand can be determined by studying the Lineweaver-Burk plots. If the y- 
intercept remains the same (with/without inhibitors), indicating that Vmax is not 
changing, then the inhibition is considered to be competitive. In this case, the inhibitor 
molecules are competing with the substrate molecules to bind in the active site of the 
enzyme. On the other hand, if the x-intercept does not change when inhibitors are 
present/not present, this indicates a constant Km, then the inhibition is considered to be 
noncompetitive. In this type of inhibition, the inhibitor does not bind in the active site 
of the enzyme and therefore must bind to another portion of the enzyme molecule. 
Other types of inhibitors do exist and will be discussed in Chapter 5.
Another important variable in studying enzyme inhibition is the Kj value. This 
term indicates the strength of the inhibition of the molecule. A lower Kj value indicates 
stronger binding between the enzyme and the inhibitor molecule and therefore is 
considered to be a more effective inhibitor. The converse is also true; the higher the Kj 
value, the weaker the interaction, and the less effective the inhibitor is considered to be. 
For pharmaceutical applications, a Kj value in the nanomolar range is considered to 
suitable for potential distribution as a drug. On the other hand, in the course of studying 
enzyme kinetics, molecules are considered to be inhibitors when the Kj  value for the 
system is in the millimolar range or lower. The K j  value can be calculated by using 
Equation 1.5 as shown below.
Equation i.5 x-intercept = -l/[Km(l+([I]/Kj»]
The x-intercept is that found from the Lineweaver Burk plot constructed while studying 
the enzyme system in the presence of an inhibitor, [I] is the concentration of the
9
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inhibitor used in the study, and Km is the Michaels-Menten constant defined for the 
enzyme system studied.
1.4 Importance of Fucose
Fucose is an important monosaccharide component of many glycoconjugates of 
species ranging from bacteria to humans. This sugar is incorporated into growing 
glycoconjugates by specific transferase enzymes that use GDP-fucose as the fucose 
donor molecules. In bacteria, fucose is part of the polysaccharides of the cell well that 
plays a part in pathogenicity.12 In the human pathogen, helicobacter pylori, which can 
lead to ulcers, the enzymatic synthesis of GDP-fucose is up-regulated in response to an 
acidic environment such as the stomach and appears to be useful in protecting the 
bacteria from the acidic conditions found in this area of the body.13 In mammals, the 
enzymatic synthesis is developmentally regulated in the rat and is know to be important
Integrins on Leukocytes 
Selectins Ig Superfamily Members on Endothelium
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in the embryonic development of mice as part of the murine embryonic antigen.14"15 In 
humans, fucose is widely distributed in many glycoconjugates. The best known
comprise an important of the sialyl lewis x (SLe*) molecule that is recognized by the 
selectin family of molecules in the cell adhesion and therefore may play an important 
role in immune function, inflammation, and metastasis.
1.5 Inflammation
The motivation for this research has been the implications in the inflammation 
process. The molecules involved in the research are involved in the early stages of the 
inflammation cascade. In the initial steps of this process are shown in Figure 1.1 
Initially, leukocytes or white blood cells are flowing through the blood vessels.17 When 
an injury such as a cut or even a heart attack occurs, signals are sent to begin the 
inflammation process to repair the damaged tissue. In the first step, the leukocytes slow 
down as they flow through the blood vessels and they actually begin to “roll” along the










Figure 1.2 Structure of the tetrasaccharide sialyl lewis x.
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surface of these blood vessels. This rolling action is mediated by selectin molecules.18' 
30 These selectin molecules are proteins which are attached either to the blood vessel 
walls (the endothelial cells) or to the leukocytes and recognize carbohydrate ligands on 
the surface of the opposite cell. The next step in this process is referred to as "tight 
adhesion” as shown in Figure 1.1. In this tight adhesion step, the leukocyte cells flatten 
out by binding tighter to the integrins and Ig superfamily of molecules on the 
endothelium cells. The final step in this process is transmembrane migration or 
extravasation of the contents of the leukocyte cells out into the injured tissue. The 
inflammation process then continues from this point by trying to rid the injured tissue of 
any foreign infection causing material.
eukocyte
P la t e le t
Endothelia l  Cell
|J-| L Selectin x . Y, Z Selectin
Y  LigandsE-Selectin
y  P- Selectin
Figure 1J  The interactions of selectins and ligands as well as the location of 
these moieties on the cell surfaces.
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The portion of this inflammation process that we are interested in is the interaction of 
SLex and the E- and P- selectin molecules.19 SLe* is the tetrasaccharide shown in 
Figure 1.2. This molecule is composed of fucose, N-acetylglucosamine, galactose, and 
neuraminic acid. It has been demonstrated by several researchers that without the 
fucose moiety in the structure of SLex, the interaction between the selectins and the 
SLex will not occur.21 If the interactions that are shown in Figure 1.3 do not occur, the 
remaining tight adhesion and transmembrane migration steps of the inflammation 
process do not occur. If these steps don’t occur, the inflammation process can be 
stopped temporarily.
GDP-fucose is the fucose donor in the enzymatic synthesis of SLex. If the 
source of GDP-fucose is removed, then SLex cannot be synthesized by the transferase 
enzyme that is responsible for adding the fucose moiety to the growing SLe* molecules. 
This is the motivation for studying the synthesis of GDP-fucose in this research project. 
As stated if the synthesis of GDP-fucose is impaired, then the synthesis of SLe* is not 
complete, and the selectin/SLe* interactions cannot occur to begin the inflammation 
process.
1.6 Leukocyte Adhesion Deficiency Disorder (LADII)
A deficiency in fucose production in the human body is a known disorder that has been 
termed Leukocyte Adhesion Deficiency type II (LADII).18' 22 This disorder is an 
autosomal recessive congenital disease, characterized by immunodeficiency, severe 
mental retardation, and growth retardation.23*24 In patients who have been diagnosed 
with this disorder, SLex is lacking on the surface of their leukocytes.23 It has been 
demonstrated that granulocytes from LADII patients fail to interact with activated
13
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endothelial cells and to bind to recombinant E-selectin in vitro experiments.25'26 These 
defects in granulocyte functions have been related to the lack of SLex expression on the 
leukocyte surface which prevents interactions with selectins thus inhibiting their tissue 
extravasation or transmembrane migration and causing the immunodeficiency. It is 
from these experiments that we believe that by effecting the synthesis of GDP-fucose. 
the inflammation process can be inhibited. By this evidence, we also believe that 
temporarily stopping the production of GDP-fucose will temporarily suspend the 
inflammatory response without damage to the human body.
1.7 Synthesis of GDP-fucose
The enzymes involved in the fucose synthesis pathway are guanosine 5'-diphospho-D- 








Guanosine 5' Diphosphate 
Figure 1.4 GDP-mannose 4,6-dehydratase enzyme reaction.
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Figure 1.5 The epimerization reaction of guanosine 5’-diphospbo-4-keto-6-D-
deoxymannose epimerase/ guanosine 5’-diphosph-4-keto-6-L-galactose 
reductase
diphospho-4-keto-6-D-deoxymannose epimerase/ guanosine 5’-diphosph-4-keto-6-L- 
galactose reductase (also known as FX protein).1Z 9‘ 27'31 These enzymes were first 
discovered and preliminarily characterized by Victor Ginsburg in the early I960’s in 
Aerobacter aerogenes}6 Later, Yurchenco and Atkinson demonstrated that this was the 
primary biosynthetic route to GDP-fucose.31 The first enzyme, GDP-mannose 4,6- 
dehydratase, converts GDP-mannose into GDP-4-keto-6-deoxymannose as shown in 
Figure 1.4. Once the GDP-4-keto-6-deoxymannose is formed in the above reaction, it 
becomes the starting material for the next step of the pathway. The FX protein is one 
enzyme that is responsible for two reactions as shown in Figures 1.5 and 1.6. The first 
reaction that the FX protein promotes is the epimerization of the hydroxyl group on the
15
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3-position of the sugar ring as well as the epimerization of the methyl group on the 6- 
position of the sugar ring. In the second reaction of the FX protein, the 4-keto group is 
reduced back to a hydroxyl group. As illustrated in the above reactions, GDP-mannose 
is converted to GDP-fucose by these two enzymes.
As mentioned previously, GDP-fucose produced by these enzymes becomes the 
supply of fucose for the synthesis of the SLex compound which is an important ligand in 
cell adhesion in the inflammatory response.19 The fucose moiety is an extremely 
important recognition of the SLex molecule while binds to E-seiectin in mediating cell 
adhesion during the inflammation response. Without the presence of this fucose portion 
of the SLex, the interaction that mediates cell rolling in the initial steps of the 
inflammation response does not occur.
1.8 GDP-mannose 4,6-dehydratase
As described in Figure 1.4, this enzyme is responsible for the first step in the 
conversion of GDP-mannose into GDP-fucose. This enzyme is expressed in many 
species including those of plant, mammals, and bacteria. For example in the 
Arabidopsis plants, a defect in the production of this enzyme affects shoot development 
in these plants. Recently, several questions have been answered about this enzyme. 
First, two studies have shown that GDP-mannose 4,6-dehydratase utilized NADP* as a 
cofactor rather than NAD* 9 This differentiates GDP-mannose 4,6-dehydratase from 
two other know sugar nucleotide dehydratases which use NAD* as their cofactor. 
Yamamoto et al. demonstrated this with enzyme isolated from Klebsilla pneumoniae 
and more recently Sturla et al. detected NADP* bound to the enzyme isolated from 
Escherichia coli (£L colt).37' 33 After cloning of the human GDP-mannose 4,6-
16





GDP-4-keto, 6-deoxy-L-glucoseV ^ GDP-L-fucose
HO OH ' Y
NH,
Guanosine S’ Diphosphate
Figure i.6 The reduction reaction of guanosine 5’-diphospho-4-keto-D-
deoxymannose epimerase/ guanosine 5’-diphosph-4-keto-6-L-gaIactose 
reductase
dehydratase enzyme, Sullivan et al. showed a distinct preference of NADP* over NAD* 
for this enzyme.9 This enzyme usually exists as a dimer in solution allowing two active 
site per dimer of enzyme. Each catalytic unit can bind two molecules of NADP* and 
two molecules of the GDP-mannose substrate. In this research project, we studied the 
GDP-mannose 4,6-dehydratase enzyme isolated from E. coli. Due to the similarities in 
the amino acid sequence and the apparent mechanism of the E. coli and the human 
GDP-mannose 4,6-dehydratase enzyme, we determined that the E. coli derived enzyme 
would serve well as a model system for identifying potential inhibitors for synthesis of 
GDP-fucose.
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C hapter 2 
M aterial and M ethods
2.1 Materials
2.1.1 Chemicals
All chemicals used in this research were used as received. All solvents used 
were of chromatographic grade or better and used without further purification. The 
reagents utilized in this research include agarose (low melting) (Amresco). potassium 
dihydrogen phosphate monobasic (Fisher), dipotassium hydrogen phosphate dibasic 
(Fisher), sodium phosphate monobasic (Fisher), sodium phosphate dibasic (Fisher), 
sodium chloride (Fisher), bactotryptone (DIFCO), bactoyeast extract (DIFCO). sodium 
hydroxide (Fisher), glycerol, isopropyl-1 -thio-/3-D-galactopyranoside (Fisher), 3-(7V- 
morpholino)ethanesulfonic acid (Sigma), ethylenediaminetetraacetic acid (Sigma), 
dithiothreitoi (Aldrich), (3-nicotinamide adenine dinucleotide phosphate (Sigma. 98%). 
(3-nicotinamide adenine dinucleotide phosphate reduced form (Sigma, 98%), guanosine 
5’-diphospho-a-L-fucose (Sigma, 80%), guanosine 5’-diphospho-D-mannose (Sigma. 
98% purity), guanosine 5’-monophosphate (Sigma), guanosine 5’-diphosphate (Sigma), 
uridine S’-diphosphogalactose (Sigma, 98%), uridine 5’-diphosphoglucose (Sigma, 
98%), tunicamycin (Sigma), 1-deoxymannojirimycin (Sigma), 1-deoxynojirimycin 
(Sigma), 1-deoxyfuconojirimycin (Toronto Research Chemicals), sodium perchlorate 
(Fisher), potassium acetate (Fisher), ultra pure polyacrylamiderbisacrylamide solution 
(37.5:1) (Amresco ultra pure grade), tris (hydroxymethyl aminomethane) (TR1S) 
(Amresco), glycine (Gibco BRL), sodium dodecylsulfate (Sigma), ammonium acetate
20
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(Amresco), N.N.N ’ ,N’ -tetramethylethylenediamine (TEMED) (Bethesda Research 
Laboratories) (electrophoresis grade), acetic acid (Fisher), methanol (Fisher), coomassie 
blue (Fisher), glucose (Fisher), phenol (Fisher), Bio-Gel A (Bio-Rad), NCOI (Gibco 
BRL), EcoRI (Gibco BRL), RNAse (Gibco BRL), and REact 3 buffer (Gibco BRL), 
pyridine (Fisher), acetic anhydride (Fisher), sodium borohydride (Sigma), 
triflouroacetic acid (Sigma), L-rhamnose (General Biochemicals).
2.13. Bacteria Cells
The TOP 10 bacteria strain was purchased from Invitrogen. The cells were 
reconstituted using Luria-Bertani (LB) growth media.1,2 This media consisted of 10 g 
bactotryptone, 5 g sodium chloride, 10 g bactoyeast extract in one liter of distilled 
water. The pH of the solution was adjusted to 7.5 using 5 M sodium hydroxide. The 
media was autoclaved at 121 °C for 20 minutes and allowed to cool to room 
temperature before use. The bacteria cells were transferred, using an inoculation loop, 
to a culture tube containing 3 mL of the LB growth. The cells were then grown 
overnight on a rotating wheel at 37 °C. Agar plates containing LB growth media were 
prepared by dissolving 5 g agar per liter of media; the solution was then heated to 
dissolve the agar. While the solution was still warm, petri dishes were filled half full 
with the agar/growth media solution and then allowed to cool to room temperature. The 
cells were plated on an agar plate and grown overnight at 37 °C. After this initial 
growth, the cells were stored at 4 °C until needed. The reconstitution procedure 
described above was carefully followed each time the cells were used in this research 
project.
21
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2.13 pSEGMD380 Plasmid
A sample of the plasmid deoxyribonucleic acid (DNA) that encodes for the enzymes 
of interest in this research was received as a gift from Genetics Institute (Cambridge, 
MA). The DNA was received in the form of a plasmid, or a naturally occurring, self- 
replicating, circular, extra-chromosomal DNA molecules naturally found in bacteria.3 
These unique fragments of plasmid DNA are widely employed in gene cloning to 
produce large amounts of desired enzyme or protein. The plasmid used in these 
experiments is pSE380 and contains an ampicillin resistance gene and lac operon 
responsible for induction of the synthesis of the dehydratase enzyme. The GDP-D- 
mannose 4,6-dehydratase gene was inserted into the pSE380 plasmid to over-express 
the GDP-D-mannose 4,6-dehydratase enzyme. After this plasmid DNA was received, it 
was transformed into the TOP 10 bacteria strain
2.2 DNA Transformation
2.2.1 Electroporation
The process known as electroporation was used to incorporate the plasmid DNA 
plasmid within the TOP 10 bacteria cells.4 In this process, the bacteria cells are 
exposed to an electric field to induce the formation of tiny openings in the cell 
membrane such that the plasmid DNA may diffuse into the cells. The TOP 10 bacteria 
cells were allowed to grow in the LB growth media overnight, washed extensively, and 
then transferred to an electroporation cuvette. This was followed by the addition of the 
plasmid DNA (5mg/mi dil 1:20) into an cuvette. The cuvette was placed in the 
electroporation apparatus and an electrical pulse was applied to the cuvette. Growth 
media was immediately added to the cuvette following electroporation.
22
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2.2.2 Growth of Transformants
The transformed cells were spread on an agar LB plate containing ampicillin. 
Cells that contained the plasmid DNA were resistant to this antibiotic allowing growth 
on the agar plate. This provides a natural selection for the cells that contain the plasmid 
with the GDP-D-mannose 4,6-dehydratase gene. The cells were then grown overnight 
in a 3 mL culture tube containing the LB growth media as well as the ampicillin (amp). 
After this growth period, an agar plate was prepared as described above except that the 
ampicillin was added to the growth media and agar solution after cooling. The cells 
were then spread on the LB-amp-agar plate and grown overnight at 37 °C. The agar 
plate was then stored at 4 °C.
2 3  Isolation and Characterization of Plasmid DNA
23.1 Miniprep of Plasmid DNA
The isolation of DNA was performed by following the procedure outlined in 
Molecular Cloning: A Laboratory Manual and will only briefly be described here.5 One 
colony of cells was transferred from the LB-amp-agar plate to a 3 mL culture tube 
containing LB growth media and ampicillin. The cells were allowed to grow overnight 
on a rotating wheel at 37 °C. The cells were then harvested by centrifugation and 
subsequent removal of the supernatant. The cells were re-suspended in SO mM glucose. 
23 mM tris Cl (pH 8.0), and 10 mM EDTA (pH 8.0). Addition of an alkali SDS 
solution lysed the cell membranes, exposing the inner cell material (DNA, RNA, and 
various proteins). Genomic DNA as well as other forms of cell debris were precipitated 
by addition of acidic 3 mM potassium acetate. Centrifugation was performed and the 
plasmid DNA was precipitated using absolute ethanol. The isolated plasmid DNA was
23
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then analyzed using agarose gel electrophoresis and compared to the plasmid DNA as it 
was received from Genetics Institute.
23.2 Analysis of Plasmid DNA
233 .1  Restriction Enzyme Digest
Restriction enzymes are defined as enzymes found in bacteria that have the 
ability to cleave double-stranded DNA.3 They are referred to as restriction enzymes 
because of their ability to “restrict” takeover of the bacteria by foreign DNA by 
destroying the DNA of the foreign species. These enzymes are programmed to 
recognize patterns of amino acid sequences and cleave at predetermined points within 
those patterns. The enzymes are used in this research to cleave the plasmid DNA into 
fragments of known size to confirm the identity of the plasmid DNA that was 
transformed into the bacteria and then re-isolated. This experiment was performed by 
examining the sequence of the plasmid DNA and determining which restriction 
enzymes would be useful in cutting the DNA into fragments of known size and 
composition. Issues of buffer and restriction enzyme compatibility had to be 
considered. The restriction enzymes used in this experiment were NCOI and EcoRl. 
NCOI recognizes the amino acid pattern 5’-CATATG-3’ and cleaves between CA TA 
creating a break in the circular plasmid DNA. The second enzyme used. EcoRI.
recognized the pattern 5’-GAATTC-3’and cleaves at 5’G A 3’ forming a fragment of
545 base pairs in length. The restriction enzyme reaction mixture consisted of 24 pL of 
10X REact 3 buffer, 4 pL NCOI, 4 pL EcoRI, 8 pL RNase, and 80 pL distilled water. 
These reactants were then carefully mixed together without vortexing. For the enzyme 
digestion of the plasmid DNA, 10 pL of the restriction enzyme reaction mixture was
24
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added to 10 |il of the plasmid DNA isolated from the mini-prep procedure. The reaction 
vessel was placed in a 37°C bath for one hour. One microliter of loading buffer was 
added to each sample and subsequently loaded on an agarose gel for analysis by 
electrophoresis. This mixture of DNA fragments is then analyzed using agarose 
electrophoresis to determine the size of the DNA fragments formed in the restriction 
enzyme reactions. The results of the restriction enzyme digestion is then compared to a 
digestion of the plasmid DNA standard (as received) to confirm the identity of the 
plasmid isolated in the mini-prep.
2 3 ^ 2  Agarose Gel Electrophoresis of DNA Fragments
As described above, the DNA plasmids and fragments generated by the 
restriction enzyme digest were analyzed by agarose gel electrophoresis.5 Agarose is a 
linear polymer extracted from seaweed; its structure is shown in Figure 2.1.
Figure 2.1 Structure of agarose polymer backbone made up of D-galactose 
and 3,6-anhydro-L-galactose.
Agarose gels are made by melting the agarose in a buffer which consists of 0.001 M 
EDTA (pH 8.0) and 0.04 M Tris-acetate, commonly referred to as TAE buffer, and then 
pouring into the gel mold and allowing to harden. As the gel hardens, a complex 
agarose matrix forms, the density of which is determined by the concentration of 




Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
charged DNA molecules migrate from the anode to cathode at neutral pH values of the 
running buffer. The DNA molecules are separated based on their molecular size as long 
as the three-dimensional structure of the DNA molecules is the same. The running 
buffer for the electrophoresis is a TAE buffer. The intercalating dye, ethidium bromide 
(EtBr), is incorporated into the running buffer such that this dye may intercalate 
between the bases in the analyte DNA; therefore, ultraviolet detection can be employed. 
The EtBr concentration is generally 0.5 /ig/mL. The apparatus used to run the gel was a 
MINNIE Submarine Agarose Gel Unit (Model HE33) manufactured by Hoefer 
Scientific Instruments (San Francisco, CA) and the high voltage power supply (Model 
SP-2717A) was manufactured by Heath Zenith. For detection, an image of the 
fluorescence from the DNA was captured using the NucleoVision detection system 
from Nucleotech Corporation and the software used to analyze the gel image was Gel 
Expert 97 v2.0.
2.4 Expression of GDP-mannose 4,6-dehydratase
Once it was confirmed that the correct plasmid DNA was transfected into the 
bacteria cells, the next step was expression of the enzyme.2 The bacteria cells were 
grown in the LB growth media. Initially a 3 mL culture was inoculated with one 
colony of bacteria cells from the LB-ampicillin agar plate from the transformation. This 
culture was incubated overnight at 37 °C on a rotating wheel to promote agitation of the 
culture. After this growth period, the 3 mL culture was transferred to one liter of sterile 
LB media and the cells were grown at 37 °C with shaking until the absorbance of the 
solution at 600 inn was 0.6. After the desired turbidity was obtained, the production of 
GDP-mannose 4,6-dehydratase was induced by adding 1 M isopropyl-1 -thio-/J-D-
26
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galactopyranoside (IPTG). The bacteria ceils were returned to the shaker and allowed 
to grow for another four hours. After the growth period, the cells were isolated by 
centrifuging in a refrigerated centrifuge at 5000 rpm for 20 minutes. After this 
clarification, the supernatant fraction was discarded and the cells were transferred to a 
plastic vial. The GDP-mannose 4,6-dehydratase enzyme is not excreted, therefore the 
cells must be lysed. This was accomplished by sonicating the cells to rupture the cell 
membranes. After sonication, the cells were centrifuged again at 5000 rpm for 30 
minutes. The supernatant fraction from this centrifugation step was loaded onto an ion- 
exchange chromatography column.
2 i  Enzyme Purification
2.5.1 Ion-exchange Chromatography of GDP-mannose 4,6-dehydratase
The first ion-exchange column that was used for the purification of this enzyme 
is diethylaminoethyl (DEAE).6 The structure of this stationary phase is shown in Figure 
2.2. The DEAE support media is used to retain negatively charged proteins to allow for
Support—  OCH2CH2-N+- h
Figure 2.2 Structure of the DEAE ion-exchange resin
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selective elution using a sodium chloride gradient. The supernatant fraction was loaded 
on this column; followed by extensive washing with 20 mM phosphate buffer (pH 7) to 
remove the proteins that do not interact with the positively charged stationary phase. 
The absorbance at 280 nm was monitored and the elution of the negatively charged 
proteins that interact with the DEAE stationary phase was begun when the absorbance 
is nearly zero (-0.005). The elution was performed using a sodium chloride gradient (0 
to 0.5 M) to add increasing amounts of small negatively charge ions to displace the 
large negatively charged proteins. A fraction collector set to collect 2 mL samples was 
used during the elution to fractionate the samples. After collection, the absorbance at 
280 nm of each sample was recorded. An elution profile of absorbance versus fraction 
number was then constructed to determine which tubes in the fraction collector 
contained proteins eluted from the DEAE column. After this was determined, a 
polyacrylamide gel electrophoresis (PAGE) experiment was performed to determine the 
molecular weights of the different fractions of proteins.
2*5.2 Polyacrylamide Gel Electrophoresis of Proteins
The polyacrylamide gels used in this work were 10 % SDS-polyacrylamide.6 
The resolving gel was prepared by mixing 2.5 mL of a 40 % w/v 
acrylamide/bisacrylamide solution, 2.5 mL of 1.5 M tris-HCl pH 8.8, 10 /zL of 10 % 
sodium dodecylsuifate, 100 flL  1 M ammonium persulfate. The mixture was diluted to 
10 ml and shaken well. After thorough mixing, 10 /zL TEMED was added to the 
solution; the gel was immediately poured into the glass plates. n-Butanol was then 
poured on top of the gel to prevent oxygen from penetrating the gel during 
polymerization. The polymerization was allowed to occur for approximately 25
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minutes. Next the stacking gel was prepared by mixing 1 mL 40 % w/v 
acrylamide/bisacrylamide, 1.25 ml 0.5 M tris-HCl ph 6.8, 50 fiL  10% SDS, 50 pi 1 M 
ammonium persulfate. The reaction mixture was diluted to 5 mL and shaken well. 
Next, 5 //L TEMED was added to the solution; the stacking gel was poured into the 
glass plates on top of the resolving gel. The comb used to form the sample wells was 
placed into the gel mixture and the polymerization was allowed to continue for 
approximately 25 minutes.
Protein samples were prepared for analysis by mixing with the loading buffer. 
The loading buffer consists of 0.05 M phosphate buffer pH 8, 2 % SDS, 10 % glycerol, 
500 /iL /J-mercaptoethanol, and bromophenol blue. Twenty /zL of the loading buffer 
was mixed with 10 /iL of the protein sample and then heated at 100 °C for two minutes. 
The samples were then ready to be loaded onto the gel for analysis. The running buffer 
for this gel consists of glycine, SDS, Tris-HCl, and water. The gel was run at 190V 
until the running marker was near the bottom of the gel, approximately 45 minutes. The 
gel was then stained using the staining solution of 2.5 g coomassie blue in 450 mL 
methanol, 450 mL water and 100 mL glacial acetic acid.
The gels were stained using the coomassie blue staining solution for 
visualization of the separated proteins. The gel was allowed to destain in a 20 % 
methanol / 10 % acetic acid solution to remove the background staining. The blue dye 
was removed from the polyacrylamide sieving matrix, but remained bound to the 
protein fragments, thus making them visible in the de-stained gel. The gels then dried 
using a Slab Gel Dryer manufactured by Hoefer Scientific Instruments (San Francisco. 
CA).
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2.6 Enzyme Assay
Once the enzyme was purified, an enzyme reaction or assay was ready to be 
performed. These assay are ail performed outside o f the body, but the conditions used 
all mimic in vitro conditions.7 The reagents used in the assay are 10 mM 3-(/V- 
morpholino)ethanesulfonic acid (MES), 1 mM ethylenediaminetetraacetic acid (EDTA), 
2 mM dithiothreitol (DTT), 100 ftM  P-nicotiamide adenine dinucleotide phosphate 
(NADP*), 10 /jM  P-nicotinamide adenine dinucleotide phosphate reduced form 
(NADPH), 100 fjM  sodium chloride, the purified GDP-mannose 4.6-dehydratase 
enzyme (0.1 mg mL*1), and the substrate GDP-mannose. All reagents were prepared 
10X the final concentration. The reaction mixtures generally consisted of 6 /tL of each 
of the reagents listed above and 12 fjL  of distilled water. An assay blank was prepared 
by mixing all reagents excluding the purified enzyme. The mixed enzyme assay 
reaction was then placed in a 37 °C for the desired reaction time. In most cases. 15 /iL 
samples were removed at 5, 10, and 15 minutes after the start of the reaction. The 
samples were prepared for analysis by high performance liquid chromatography 
(HPLC) as described below.
2.7 High Performance Liquid Chromatography Analysis of Enzyme Assays
2.7.1 HPLC Sample Preparation
The enzyme assay samples were prepared for analysis for HPLC by first 
stopping the enzyme reaction; this was accomplished by boiling the samples at 100 °C 
for two minutes.8 The samples were cooled and 1 M sodium perchlorate (pH 4.1) was 
added to the samples followed by incubation at 4 °C for 15 minutes. After the 
incubation period, 1 M potassium acetate was added to the samples and again they were
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incubated at 4  °C for 15 minutes. The samples were then stored at -20 °C until analysis 
by HPLC.
2.7.2 HPLC Analysis Conditions
The HPLC separation conditions used to analyze the sugar nucleotide 
compounds are as described; development of these conditions will be discussed later in 
subsequent depth. Isocratic separation conditions employing a 0.5 M phosphate buffer 
at pH 6.20 with a flow rate of 0.5 mL min'1 were used. The HPLC used consists of a 
manual injector, solvent mixer, two Rainin HPX pumps, a Nucleosil octadecyl coated 
column (Macherey-Nagal), and a Knaur ultra-violet/visible detector. Generally, 30 /iL 
samples were injected. The detection method included monitoring ultra-violet (UV) 
absorbance at 254 nm.
2.73 Analysis of GDP-4-keto-6-deoxymannose Isolated from the HPLC Analysis
The GDP-4-keto-6-deoxymannose peak in the chromatogram was isolated after 
elution from the detector and analyzed further to confirm its identity. This reaction 
scheme is illustrated in Figure 2.3. The first step in this analysis was to reduce the 4- 
keto intermediate moiety back to a hydroxyl group. This was achieved by treating the 
sample with 0.2 M sodium borohydride at room temperature for 15 minutes. The 
sample was dried under nitrogen and 1 M trifluoroacetic acid was added to cleave the 
nucleotide base from the sugar moiety of the molecule. This reaction was performed at 
100 °C for 15 minutes and dried under N2. Next the sample was reacted with 1:1 
pyridine:acetic anhydride to acetylate the sugar molecule for gas chromatography mass 
spectrometry (GC-MS) analysis. A standard rhamnose sample was prepared for use as 
a reference to aid in the determination of the identity of unknown samples.
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Figure 1 3  Reaction scheme illustrating the analysis of GDP-4-keto-6- 
deoxymannose
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2.8 Theory of Polyacrylamide Gel Electrophoresis
Polyacrylamide gel electrophoresis is an electrophoretic technique used in this 
case to separate proteins based on their molecular weight.5 In this analysis, the proteins 
are complexed with the strong anionic detergent sodium dodecylsulfate (SDS). The 
amount of SDS that is bound to the protein is almost always proportional to the 
molecular weight of the protein, therefore, by comparing the migration of the unknown 
protein to that of standard proteins of known molecular weight, the molecular weight of 
the unknown can be estimated. The electrophoresis is carried out using a discontinuous 
buffer system. The running buffer used to separate the analytes is of a different pH and 
ionic strength than that of the buffer used to cast the gel. The SDS-protein complexes 
are swept along the moving boundary formed when the current is passed between the 
electrodes. The samples are first moved through a high porosity stacking gel to form a 
thin layer of samples along the resolving gel. The chloride ions in the sample and the 
stacking gel form the leading edge of the moving boundary and the trailing edge is 
formed by glycine molecules. Between these two edges lies a region of lower 
conductivity and steeper voltage gradient which moves the proteins from the sample 
through the stacking gel and onto the resolving gel. The higher pH of the resolving gel 
ionizes the glycine molecules; the resulting ionized glycine molecules migrate through 
the stacked proteins and travel through the resolving gel directly behind the chloride 
ions. This eliminates the region of lower conductivity and steeper voltage allowing the 
proteins to be separated by sieving based on their size. By adjusting the percentage of 
acrylamide in the resolving gels, the range of molecular weights that can be separated 
by these gels can be controlled.
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2.9 High performance Liquid Chromatography
High performance liquid chromatography, HPLC, is a separation technique used to 
analyze many different types of molecules such as macromolecules, ionic species, and 
labile natural products.9 The basis of the separation in this technique is the partitioning 
of the analytes between the stationary phase and the mobile phase used in the separation 
system. Two modes of separation exist in HPLC, normal phase and reversed phase. 
Normal phase refers to separation conditions using a polar stationary phase such as 
silica and a non-polar mobile phase such as chloroform. These conditions are useful in 
separating non-polar analytes. In contrast, reversed phase HPLC employs a non-polar 
stationary phase such as an octadecyl coating on a solid support and a polar mobile 
phase such as a phosphate buffer. Reversed phase HPLC is useful in separating ionic or 
polar compounds such as sugar nucleotides studied in this research. The analytes 
studied in this project were separated using the HPLC method that was developed as 
discussed in Chapter 4.
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C hapter 3 
C om petent Cell Form ation and Expression and Purification of 
GDP-mannose 4,6-dehydratase
3.1 Introduction
Molecular cloning refers the technology that allows the isolation and 
propagation of identical molecules of DNA in a host organism.1 This technology is 
very powerful in the study of biochemistry and allows for the study of enzymes and 
other molecules that prior to the development of these techniques were difficult. This 
process consists of two separate phases the first of which is to insert the DNA of interest 
into a cloning vector.2 This vector is then placed into the host organism where the DNA 
can replicate to produce more of the desired protein. The cloning vector used in this 
research is the pSE380 plasmid. This plasmid contains an ampicillin resistance gene 
and the lac operon site. The ampicillin resistance is now a property of the cells that 
contain the plasmid and can therefore be used as a natural selection process for the cells 
that contain the plasmid. Cells that do not contain the ampicillin resistance gene will 
not survive in the presence of this antibiotic, but the ones that contain the plasmid will 
flourish. The lac operon controls transcription of the DNA by using a trigger for /J- 
galactosidase activity. The molecule used to stimulate the lac operon is isopropyl-p- 
galactopyranoside (IPTG) which mimics the structure of the actual substrate for the 
galactoside enzyme, lactose. When the IPTG is present in the growth media, it sends a 
signal to the transcription system to start transcription that produces the GDP-mannose
4,6-dehydratase enzyme. The plasmid containing the DNA for the GDP-mannose 4,6- 
dehydratase enzyme was received as a gift from Genetics Institute as stated in Chapter 2 
and did not need to be prepared. Results from the second step of the molecular cloning
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process, the transformation of the cloning vector into the host organism will be 
discussed in this chapter.
3.2 Electroporation Results
As stated in Chapter 2 of this document, the plasmid was inserted into the host 
E. coli bacteria by the process known as electroporation and will not be discussed here.
1 2 3 4 5 6 7 8
Figure 3.1 Picture of agarose gel showing the migration of plasmid DNA isolated 
from TOP 10 bacteria cells. In this gel, lanes one, five, seven, and eight 
are empty. Lane two is the one kilobase pair ladder standard and lane 
six is the Hind IV standard. The sample of plasmid DNA isolated from 
the TOP 10 bacteria strain is shown in lane four. A reference sample 
of plasmid DNA as received from Genetics Institute is shown In lane 
three.
To ensure that the correct plasmid DNA was transformed into the bacteria cells, it was 
necessary to isolate the plasmid DNA from the bacteria cells by the mini-prep
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procedure outlined in Chapter 2. The isolated DNA was analyzed using agarose gel 
electrophoresis and the results of this isolation are shown above in Figure 3.1.
This gel image shows the results of the electrophoresis analysis of plasmid DNA 
isolated from the TOPIO bacteria, a reference sample of the plasmid DNA as it was 
received from Genetics Institute, as well as DNA markers. Lanes one, five, seven, and 
eight are empty on the gel shown. Lane two is the one kilobase pair ladder standard and 
lane six is the Hind IV restriction enzyme digest standard. The sample of plasmid DNA 
isolated from the TOP 10 bacteria strain is shown in lane four. The reference sample of 
plasmid DNA can be seen in lane three. As is shown in this gel, the standard plasmid 
DNA and the DNA isolated from the bacteria cells after transformation appear to have 
the same number of base pair indicating that these are the same size plasmid.
G D P -M annose  4,6-dehydratase gene
N C 0 1  recognit ion site
EcoR 1 recognit ion site




P S E G M D  380
Figure 3.2 Diagram of pSEGMD380 plasmid showing the recognition sites of 
NCOl and EcoRl and the GDP-mannose 4,6-dehydratase gene
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After electrophoretic analysis, plasmid DNA was subjected to a restriction 
enzyme digest and then agarose gel electrophoresis again. The restriction enzymes used 
in this experiment were NCOI and ECORL When these two enzymes are used in 
combination to cleave the pSEGMD380 plasmid, a fragment of DNA 545 base pairs in 
length results. The remaining fragment of DNA is approximately 3931 base pairs in 
length. A diagram of this pSEGMD380 plasmid with the restriction enzyme 
recognition sites is shown in Figure 3.2. Once this digestion was performed, it was 
analyzed using agarose gel electrophoresis. The results of this digestion are shown in 
Figure 3.3.
1 2 3 4 5
Figure 3 3  Picture of agarose gel showing the migration of DNA fragments 
that were created as a result of a restriction enzyme digest. Lane 
one is XH3 standard, lanes two and four are samples of the 
plasmid DNA isolated after digestion with the restriction enzymes, 
lane three is a sample of the standard plasmid DNA received from 
Genetics Institute after digestion with the restriction enzymes, and 
lane five is a base pair standard where each band indicates an increase 
of 100 base pairs.
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Shown in the gel image above in Figure 3.3, lane one is Aii3 standard, lanes two 
and four are samples of the plasmid DNA isolated after digestion with the restriction 
enzymes, lane three is a sample of the standard plasmid DNA received from Genetics 
Institute after digestion with the restriction enzymes, and lane five is a base pair 
standard where each band indicates an increase of 100 base pairs. The lower bands in 
lanes two, three, and four is in line between the 500 and 600 base pair bands in the 
standard shown in lane 5. The expected size of this band is 545 and based on the 
location of this band on the gel, it is determined to be between 500 and 600 base pairs 
indicating that this is the correct plasmid. Also, the standard plasmid DNA received 
from Genetics Institute has a band of base pairs that has the same migration as those 
shown for the samples. This is another indicator that the pSEGMD380 plasmid was 
successfully incorporated into the E. coli bacteria as described above.
3 3  Expression of GDP-mannose 4,6-dehydratase
After these agarose gel electrophoresis experiments confirmed that the plasmid 
DNA incorporated into the E. coli cells was the correct plasmid that contained the GDP- 
mannose 4,6-dehydratase gene, the enzyme now had to be expressed or produced. This 
was done by the procedure outline in Chapter two. Briefly, the cells were grown to a 
particular growth level and then the EPTG was added in order to begin production of the 
enzyme by signaling the production of mRNA for the GDP-mannose 4.6-dehydratase. 
This growth period was allowed to continue for approximately four hours and then the 
cells were harvested and lysed as described in Chapter 2. After this expression, GDP- 
mannose 4,6-dehydratase was ready for purification.
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3.4 Purification of GDP-mannose 4,6-dehydratase
3.4.1 DEAE Column Purification
The first step in the purification of GDP-mannose 4,6-dehydratase enzyme was 
to use ion-exchange chromatography.3 The first column used as described in Chapter 2 
was the DEAE column, a positively charged resin used to retain negatively charged 
proteins as indicated in Figure 2.2. This purification step passes positively charged 
proteins and retards those carrying a net negative charge. Negatively charged proteins.
Dehydratase Elution from  DEAE Biogel A Column
3.5 
3.0 
g  2.5 
§ 2.0 
1  1-5 
<  1.0 
0.5 
0.0
0 20 40 60 80
Tube Number
Figure 3.4 Elution profile of eluant from DEAE column
which interact with the column, must be eluted with varying concentrations of a counter 
ion. The protein was loaded onto the column, washed to remove the unbound protein, 
and then eluted from the column with a sodium chloride gradient. As the protein was 
eluted from the column, it was collected using a fraction collector set to collect 2 mL 
per tube with 80 tubes in each collection rack. The first analysis of these fractions was
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to record the absorbance of each fraction at 280 tun. From this data an elution profile as 
shown in Figure 3.4 was constructed.
The tube number in the elution profile refers to the position of the tube in the 
fraction collector and the absorbance indicates whether or not that particular fraction 
contains protein. As can be seen in Figure 3.4, fractions 20-50 contain protein and 
create one peak in the elution profile while fractions 51-75 contain different proteins 
and create the second peak in the elution profile. The information gained from the 
elution profile indicates which fractions contain protein and these fractions now need to 
be analyzed further to determine which of these fractions contain the GDP-mannose
4,6-dehydratase enzyme.
200000
1 1 6 0 0 0
9 6 0 0 0
6 6 0 0 0
4 5 0 0 0
Figure 3.5 Gel Image of PAGE experiments on eluent from DEAE column.
Lane one is a high molecular weight standard, lane two is tube 20 
from the fraction collector, lane three is tube 25, lane four is tube 
27, lane five is tube 29, lane six is tube 31, lane seven is tube 35, lane 
eight is tube 37, lane nine is tube 38, and lane ten is tube 40. As 
shown in the gel above, lanes five, six, and seven contain large 
amounts of protein (indicated by the intensity of the band) that 
correspond to a molecular weight of approximately 40kD
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The next step in the analysis of these fractions was polyacrylamide gel 
electrophoresis (PAGE).3,4 This was performed to gain a molecular weight profile for 
each of the fractions indicated in the elution profile to contain protein. Figure 3.5 
shows the PAGE gels resulting from analysis of the fractions. The observed molecular 
weight of the GDP-mannose 4,6-dehydratase enzyme is 40kD based on work shown by 
Tonetti and Sullivan.6,7 In the gel shown, lane one is a high molecular weight standard, 
lane two is tube 20 from the fraction collector, lane three is tube 25. lane four is tube 27. 
lane five is tube 29, lane six is tube 31, lane seven is tube 35, lane eight is tube 37. lane 
nine is tube 38, and lane ten is tube 40. As shown in the gel above, lanes five, six. and 
seven contain large amounts of protein (indicated by the intensity of the band) that 
correspond to a molecular weight of approximately 40kD. This corresponds to tube 
numbers 29-35. These fractions were then pooled together and loaded onto the second 
ion-exchange column for the next step in the purification.
3.4.2 Hydroxyapatite Column Purification
The second ion-exchange column used in this purification is a hyrdoxyapatite 
(HA) column. This ion-exchange media consists of clusters of Ca2(P04b0H  or 
Caio(P0 4 )6(OHh.8 This column is generally used in the final steps of protein 
purification. Two different types of interactions may occur with this column. 
Positively charged proteins interact with negatively charged phosphate groups while 
negatively charged proteins may interact with the positively charged calcium ions. The 
negatively charged proteins with molecular weights of approximately 40kD from the 
DEAE column were loaded onto this HA column. Once these proteins were loaded 
onto the column and the column was washed, elution was done using a phosphate buffer
43
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
of constant pH but varying phosphate concentrations to elute the negatively charged 
proteins. As before, a fraction collector was used to collect two mL per tube. The 
absorbance of these fraction was recorded and an elution profile for the HA column 
eluant was then constructed as shown below in Figure 3.6.
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Figure 3.6 Elution profile of eluant from HA column
Fractions that contain protein are tubes 18-22, 23-32, 33-53, and 56-61. These are 
fractions that were analyzed by PAGE to estimate the molecular weight of proteins 
contained in each fraction. This experiment was performed as described in Chapter 2. 
The result of this analysis is shown below in Figure 3.7.
Only the PAGE analysis of fractions 18 -  40 are shown in this gel. Lane one is 
the high molecular weight standard, lane two is tube 18, lane three is tube 22, lane four 
is tube 25, lane five is tube 28, lane six is tube 30, lane seven is tube 33, lane eight is
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Figure 3.7 Gel Images of the PAGE experiments on the HA column eluent.
Lane one is the high molecular weight standard, lane two is tube 18 
from the fraction collector, lane three is tube 22, lane four is tube 
25, lane five is tube 28, lane six is tube 30, lane seven is tube 33, lane 
eight is tube 35, lane nine is tube 37, and lane ten is tube 40.
tube 35, lane nine is tube 37, and lane ten is tube 40. It can be seen in Figure 3.7 that 
each of the fractions analyzed contains protein with the desired molecular weight of 
approximately 40 kD. Tubes 35-40 contain more of the GDP-mannose 4.6-dehydratase 
enzyme and fewer bands due to other proteins.
The protein from the HA column was used for an enzyme assay and this assay 
was analyzed using the HPLC method developed as will be discussed in the following 
chapter.
3.5 Conclusions
This chapter illustrates that the plasmid DNA received from Genetics Institute 
was incorporated into E. coli Top 10 bacteria cells for use in the expression of GDP- 
mannose 4,6-dehydratase. The agarose gel electrophoresis experiments analyzed the 
plasmid DNA and have shown that the plasmid DNA was incorporated into the bacteria 
cells used. After transfection of bacteria cells, the bacteria was then used to synthesize
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GDP-mannose 4,6-dehydratase for use in the inhibitor analyses that will be discussed in
Chapter S. The purification of this enzyme for use in these later assays was described
and supported by the polyacrylamide gel electrophoresis data shown. This enzyme is
now purified and ready for the analysis of its kinetic properties.
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C hapter 4 
H PLC M ethod Development for G uanosine Nucleotides and 
Guanosine and Sugar Nucleotides
4.1 Introduction
Nucleotides and nucleotide molecules with sugars attached, known as sugar 
nucleotides, serve many roles in prokaryotic and eukaryotic cells. For nucleotides these 
roles include energy storage molecules by varying the number of phosphate groups 
attached to the nucleobase, and cofactors that are reduced or oxidized providing protons 
or electrons for various biochemical reactions.1 On the other hand, sugar nucleotides 
are used as glycosyl donors in many reactions such as the synthesis of bacterial 
peptidoglycans. These sugar nucleotide molecules were first discovered by Dr. Luis 
Leloir and subsequently earned him the Nobel Prize in Chemistry in 1970.2 He 
discovered these molecules by studying conversion of one monosaccharide to another in 
carbohydrate biosynthesis. Sugar nucleotides were described as the molecules essential 
to this conversion by activating the sugar moiety and therefore leading to the synthesis 
of different carbohydrates. These molecules also participate in the synthesis of 
polysaccharides by providing the sugar moiety which is transferred to the growing 
polysaccharide chain. The sugar nucleotide molecules studied in this research are 
guanosine S’-diphospho-D-mannose (GDP-mannose), guanosine 5’-diphospho-L-fucose 
(GDP-fucose), and the nucleotide metabolites of these sugar nucleotides studied are 
guanosine S’-diphosphate (GDP) and guanosine 5’-monophosphate (GMP).
Various high performance chromatography (HPLC) methods have been used to 
separate nucleotides and sugar nucleotides, including anion exchange HPLC,3 ion-pair
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HPLC,4 and recently ion-pair reversed phase HPLC.5 These methods involve steps such 
as pre-column reactions of the sugar nucleotides and borate buffers to form borate-sugar 
nucleotide complexes which are then used to separate the sugar nucleotides from each 
other as well as from the nucleotides.6 Other methods include addition of a counter-ion 
such as tetrabutylammonium hydrogen sulfate to the mobile phase in ion-pair HPLC. 
Also anion exchange columns have been used in the separation of these compounds. 
These methods generally involve a pre-column reaction and/or gradient elution of the 
nucleotides and sugar nucleotides. Methods previously discussed in the literature 
mainly describe the separation of uridine nucleotides and 4’ epimeric sugar nucleotides 
such as glucose and galactose sugar nucleotides. The work described here compares a 
reverse phase octadecyl column and a Nucleosil column in an isocratic separation of 
guanosine nucleotides and sugar nucleotides. By using this method, pre-column 
reactions and gradient elutions are eliminated and also a reliable method for the 
separation of guanosine nucleotides is established.
This method was developed for use with the pathway responsible for the 
conversion of guanosine 5’-diphospho-D-mannose (GDP-mannose) to guanosine 5’- 
diphospho-L-fucose (GDP-fucose).7'9 It will be shown that this HPLC method 
developed can be used as an assay for monitoring the synthesis of the GDP-4-keto-6- 
deoxymannose which is the product of the GDP-mannose 4,6-dehydratase enzyme as 
well as the substrate for guanosine 5’-diphospho-4-keto-6-D-deoxymannose 
epimerase/guanosine 5’-diphospho-4-keto-6-L-galactose reductase. This is illustrated 
by analysis of the GDP-4-keto-6-deoxymannose peak for the presence of rhamnose
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after reduction of the 4-keto group and cleaving of the GDP moiety from the sugar 
nucleotide.
4J2 High-Performance Liquid Chromatography (HPLC) Studies.
The high-performance liquid chromatography (HPLC) system employed in this 
work consisted of two Ramin (now Varian Walnut Creek, CA) HPX pumps, manual 
injector, solvent mixer, and a Knaur (Germany) ultra-violet/visible (UV-vis) absorbance 
detector. The data was collected and analyzed using the Dynamax HPLC method 
manager software by Rainin.
The separation of these compounds was tested using two types of columns. The 
first was a Rainin axial compression Ci8-coated silica packed column (250 X 4.6 mm) 
with an average particle size of 5 pm. This column was preceded by a Rainin Dynamax 
Qg-coated silica packed guard column (6 cm length with a 12 pm particle size). The 
second column used in these experiments was a Macherey-Nagal (Easton, PA) 
Nucleosil Cig-coated silica packed column (250 X 4.6 mm) with an average particle size 
of 5 pm. These two columns, the traditional Cig-coated silica packed column and the 
Nucleosil Cig-coated silica packed column, were compared in this study.
The mobile phase system consisted of a 0.5 M phosphate buffer. This buffer 
was prepared by titrating 0.5 M potassium dihydrogen phosphate and a 0.5 M 
dipotassium hydrogen phosphate solutions until the desired pH was achieved. The pH 
values of the mobile phases tested in this procedure ranged from 4 to 7. The mobile 
phase buffers were filtered through a 0.45 pm filter and degassed by bubbling nitrogen 
through the solution. The mobile phase solutions were stored at 4 °C and allowed to 
warm to room temperature before use.
49
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
Standard samples were prepared by dissolving the nucleotide or sugar nucleotide 
in 18 M£2 cm water (Bamstead Nanopure system) to a concentration of 1 mg/ml. These 
solutions were stored at 4 °C until sample injection.
4 3  Enzyme Reaction Conditions
The GDP-mannose 4,6-dehydratase enzyme was expressed and purified as 
described in Chapter 3. Typical reaction conditions for the synthesis of GDP-4-keto-6- 
deoxymannose using the GDP-mannose 4,6-dehydratase enzyme were as follows: 10 
mM GDP-mannose, 10 mM MES (pH 6.5), 10 pM NADP, 100 (iM NADP+. 100 (iM 
NaCl, 2 mM DTT, 1 mM EDTA, and the GDP-mannose 4,6-dehydratase enzyme 
purified as described above (approximate concentration 0.5 mg/ml). The reaction 
mixture was placed in a 37 °C water bath and aliquots were removed every hour. The 
reaction progress of this enzyme assay was monitored using the HPLC method 
described in this work. The samples were prepared for HPLC analysis by the 
procedure described by Martin et al.u Briefly, the samples were denatured by heating 
at 100 °C and adding sodium perchlorate followed by incubation at 4 °C for 15 minutes. 
Potassium acetate was then added to the samples and they were further incubated at 4 
°C. The samples were filtered though a 0.45 pm filters before injection.
4.4 Analysis of GDP-4-keto-6-deoxymannose
The GDP-4-keto-6-deoxymannose peak that indeed elutes from the HPLC 
around 11 minutes was analyzed to confirm that this was the intermediate for the 
enzyme reaction. This analysis was done by first reducing the keto functionality in the 
four position on the sugar ring by adding 0.2 M sodium borohydride to a sample 
thought to contain the GDP-4-keto-6-deoxymannose compound. This reaction was
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allowed to take place for IS minutes at room temperature. The products from this 
reaction scheme are GDP-6-deoxy-D-talose and GDP-D-rhamnose. The sugar moiety 
was cleaved from the nucleotide base by adding 1 M trichloroacetic acid to the sample 
and boiling for 10 minutes. The products from this reaction, 6-deoxy-talose and 
Rhamnose, were derivatized with pyridineracetic anhydride (1:1) to acetylate the 
hydroxyl groups of the sugar ring for gas chromatography-mass spectrometry (GC-MS) 
analysis of the products.
4.5 pH Dependence of the Separation
Several methods have been utilized for the separation of nucleotides and sugar 
nucleotides. Because these molecules are charged in the range of pH 2 to 8, the method 
of choice has been one that involves the use of a counter-ion and gradient elution to aid 
in the separation. The method developed here is an isocratic separation that does not 
require a counter-ion and eliminates problems associated with gradient elutions such as 
reproducibility of the gradient, column equilibration, etc. Because these molecules are 
charged over a wide pH range, our first goal was to determine at which pH value the 
best separation would be obtained.
Numerous experiments were conducted to determine the optimum separation 
conditions for the analytes in question. The purpose of one set of experiments was to 
determine the optimum pH for use in the separation of these molecules. The majority of 
these experiments were performed using the Rainin octadecyl column. This was 
executed by preparing the 0.5 M phosphate buffer mobile phase with a different ratio of 
potassium dihydrogen phosphate (monobasic phosphate) to dipotassium hydrogen 
phosphate (dibasic phosphate) to achieve the desired pH values. The pH values tested
51
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
ranged from 4 to 7. These values were chosen based on previous studies found in the 
literature. The most dramatic changes in resolution of the separation were observed 
between pH 6.1 to 6.6, Figure 4.1 A-D. At pH 6.13, displayed in Figure 4.1 A. only two 
peaks are observed in the chromatogram. The peak at 9.28 min represents GDP and 
GDP-mannose co-eluting. GMP is represented by the later peak in the chromatogram, 
11.08 min. When the pH is increased to 6.23, Figure 4. IB, three peaks are evident in 
the chromatogram. The first peak at 10.12 min corresponds to GDP; the second peak at 
10.62 min is GDP-mannose, and the third peak is GMP, elution time 11.38 min. By this 
data, it is evident that a slight increase in the pH (0.10 units) leads to better separation. 
Further increasing pH to 6.31 as shown in Figure 4.1C, the first peak represents GDP 
alone, while the second peak represents GDP-mannose and GMP coeluting instead of 
GDP and GDP-mannose as before. We again increased the pH, this time to 6.61. and 
the chromatogram shown in Figure 4. ID, has only one peak. All three components of 
the standard mixture (GDP, GDP-mannose, and GMP) coelute to makeup this one peak. 
Table 4.1 pKa Values for Guanosine Nucleotides
GDP GMP
Primary Phosphate <1 <1
Secondary Phosphate 6.3 6.1
Nucleotide Base 2.9,9.4 2.9. 9.4
Figure 4.1 illustrates that a slight change in pH can have a large effect on the 
separation of these compounds. We believe this phenomenon can be explained by 
studying the secondary pKa values for the analytes, which as shown in Table 4.1. range
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Figure 4.1. Chromatograms showing separation of GDP, GDP-mannose and GMP using 
0.5 M phosphate buffer with varying pH values, left to right (a) Mobile 
phase pH 6.13 (b) Mobile phase pH 6.23 (c) Mobile phase pH 631 (d)
Mobile phase pH 6.61
from 6.0 to 6.5. This corresponds to the pH range where the largest change in 
resolution is observed in the chromatogram with the smallest change in pH values of the 
mobile phase. We believe this change in resolution if due to the ionization of the
53
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
secondary phosphate groups of these molecules which occurs when the pH equals the 
pKa value. The charging of this secondary phosphate group changes the interaction of 
the analyte with stationary phase enough such that a change in resolution is observed.
4.6 Comparison of Octadecyl and Nucleosil Columns
As is evident from the chromatograms in Figure 4.1 illustrating the results of 
separating these analytes on a standard octadecyl column, the separation of these 
compounds needs improvement. Two main things for improving are the resolution and 
the peak shape of these analytes. First of all, the peaks tail in the chromatograms. 
Secondly, complete separation of the analytes was not achieved by using this column 
with the phosphate buffer mobile phase at any pH value. We attribute the peak tailing 
in these chromatograms to residual silanol groups on the HPLC column packing 
interacting with these very polar analytes causing them to be retained on the column 
longer and therefore causing the tailing observed in these chromatograms. These 
problems in the separation can be corrected by using the nucleosil column in which the 
residual silanol groups have been thoroughly endcapped to allow for the analysis of 
very polar analytes such has oligonucleotides. As shown in Figure 4.2A, the tailing 
problem evident in the traditional Cis column chromatogram (Figure 4.2B) has been 
alleviated. The data shown in Figure 4.2A-B was collected at optimum separation 
conditions (0.5 M phosphate buffer pH 6.2 flowing at 0.5 ml/min. Also the compounds 
now completely resolve from one another on the Nucleosil column.
Martin et al. present an HPLC method to separate GDP-mannose and GDP- 
fucose.11 In this paper the authors discuss the study of GDP-Mannose and GDP-fucose
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Figure 4.2 Chromatograms showing separation of GDP, GDP-mannose, and GMP 
using 0.5 M phosphate buffer a Nucleosil column, top to bottom (a) 
mobile phase pH 6.13 (b) mobile phase pH 6.22 (c) mobile phase pH 637
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metabolism using both an anion exchange column and a traditional C|8 column. This 
work does not mention the separation of free guanosine nucleotides and the nucleotide 
sugars. Radioactivity measurements were used as the detection scheme. The separation 
which was achieved using the traditional Qg column by Martin et al. is comparable to 
the results obtain in the work describe here for GDP-mannose and GDP-fucose using 
the Rainin octadecyl column. Again, this work does not show the separation of the 
sugar nucleotide and the nucleotide molecules.
4.7 Analysis of Products from GDP-mannose 4,6-dehydratase Using the HPLC
Method Developed
The GDP-mannose 4,6-dehydratase enzyme discussed previously was assayed 
using the HPLC method developed in this work. As can be seen in Figure 4.3, the 
substrate, GDP-mannose, is the first peak in the chromatogram, while the product of 
this enzyme, GDP-4-keto-6-deoxymannose, is the later eluting peak. A time study was 
performed in order to determine the optimum reaction time for the enzyme assay. After 
just one hour, a small peak is visible in the chromatogram representing the product. As 
the reaction time increases, the area associated with the product peak increases, and. 
conversely, the area of the substrate, GDP-mannose, decreases. This study illustrates 
that the chromatographic method developed here is an effective assay tool for studying 
this enzyme.
Analysis of the GDP-4-keto-6-deoxymannose peak was performed as discussed in 
Chapter 2 and analyzed using GC-MS. Rhamnose is concluded to be present in the GC- 
MS chromatograms from the analysis of the sample that was isolated from the HPLC 
eluent with a retention time of around 11 minutes and a mass spectrum that matches that
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Figure 4 3  Analysis of GDP 4,6-dehydratase assay using HPLC method developed in 
this work.
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Figure 4.4 GC-MS trace showing elution of acetylated rhamnose.
of the acetylated rhamnose standards. The results of these experiments are shown in 
Figures 4.4 and 4.5. The two peaks observed in this chromatogram are a  and P anomer 
configurations of the acetylated rhamnose. These two peaks can be seen in both the 
standard or reference samples as well as those analyzed from the HPLC. The source 
for the rhamnose that was detected in the analysis of the compound that elutes from the 
HPLC around 11 minutes when analyzing the products of the GDP-mannose 4.6- 
dehydratase enzyme is GDP-mannose-4-keto-6-deoxymannose which must be present 
as the starting material for the reactions outline in Figure 2.3. This GC-MS data 
indicates that the second peak in the HPLC chromatogram is GDP-4-keto-6- 
deoxymannose by identifying acetylated rhamnose in the GC-MS analysis after 
reduction of the 4-keto group, cleaving the GDP moiety from the sugar nucleotide, and
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acetylation of the resulting monosaccharide. The major product after these reactions is 
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Figure 4.5 Enlargement of GC-MS trace showing elution of two peaks for 
acetylated rhamnose.
4.8 Conclusions
This work has shown that by using a nucleosil column and phosphate buffer 
mobile phase in an isocratic separation, guanosine nucleotides and sugar nucleotides 
can be successfully separated. This can be achieved with little or no sample preparation 
due to the fact that no derivatization or complexation is needed to separate these 
compounds using this method. An isocratic separation using a 0.S M phosphate buffer 
adjusted to a pH of 6.23 produced the best separation on either column tested in this 
work. This method will be used to study more in depth the enzymes responsible for 
the conversion of GDP-mannose to GDP-fucose, namely GDP-mannose 4,6-
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dehydratase and guanosine 5 ’ -diphospho4-keto-6-D-deoxymannose
epimerase/guanosine 5 ’ -diphospho-4-keto-6-L-galactose reductase (also know as the 
FX protein). This method can also be useful in studying enzymes where the 
monosaccharide portion of the sugar nucleotide is transferred to a growing molecule 
and the nucleotide portion is free. This nucleotide will be available for detection, 
leaving it as a marker for the reaction progress.
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C hapter 5 
K inetics and Inhibition of GDP-mannose 4,6-dehydratase
5.1 Introduction
Studying the kinetics of enzyme reactions is very important in understanding a 
biochemical system. Enzymes work by lowering the energy of activation for a reaction 
and therefore catalyzing this reaction. This is done by stabilizing the transition state of 
the reaction, bringing it to lower energy, thus making the reaction more favorable to 
proceed. As mentioned in Chapter 1, enzyme catalyzed reactions proceed 103 to 1016 
times faster than uncatalyzed reactions.1
Molecules that cause the enzymatic reactions to slow or stop are referred to as 
inhibitors. These inhibitor molecules can act in several ways. Two general classes of 
inhibitors exist, reversible and irreversible.2 Reversible inhibitors bind to the enzyme in 
a reversible fashion and can be removed from the enzyme by dialysis or diluting to 
restore full enzyme activity. On the other hand, an irreversible inhibitor cannot be 
removed from the enzyme and usually destroy enzyme activity. Examples of 
reversible inhibition include competitive inhibition. In the case of competitive 
inhibition, the inhibitor binds in the active site and therefore competes with the substrate 
for binding in this region of the enzyme. Competitive inhibitors, in general, structurally 
resemble the substrate of the enzyme and therefore are usually recognized by the active 
site of the enzyme. In this research, the potential inhibitor molecules were selected on 
the basis of their structure and therefore, we expect to see competitive inhibition for this 
enzyme. Two other types of reversible inhibition include uncompetitive inhibition and 
noncompetitive inhibition. In the case of uncompetitive inhibition, the inhibitor
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molecule binds to the already formed enzyme-substrate complex to stop the enzyme 
reaction. Noncompetitive inhibitors bind to a location on the enzyme that is not the 
active site and therefore don't compete with the substrate.
5.2 Kinetic Analysis of Purified GDP-mannose 4,6-dehydratase
The GDP-mannose 4,6-dehydratase enzyme was purified as outlined in Chapter 3. 
An enzyme assay was then performed as indicated in the materials and methods chapter. 
The reactions were all performed in triplicate and the substrate concentrations used in 
these experiments were 200, 250, and 300 fjM. Samples were collected at 5, 10, and 15
Lineweaver-Burk Plot
o
2 0 2 4 6
[GDP-Man] X10*3 (liter/^mole)
Figure 5.1 Lineweaver-Burk plot for GDP-mannose 4,6-dehydratase with 
GDP-mannose as substrate.
minutes of reaction time. With these conditions, an estimate of the reaction velocity can 
reliably be calculated from the data collected. For each assay an enzyme blank sample
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was prepared and analyzed. A typical Lineweaver-Burk plot for the GDP-mannose 4,6- 
dehydratase enzyme is shown below in Figure 5.1. The Km value for this enzyme was 
calculated to be 283.3+12.3 /zM. This indicates that at a substrate concentration of 280 
fiM  approximately half of the enzyme active sites contain a substrate molecule. When 
the substrate concentration is at or near the Km value, enzymes are the most sensitive to 
changes in the reaction mixture and therefore, this is the optimum concentration to use 
while performing inhibition analysis. This is the reason the inhibition assays were 
performed using GDP-mannose concentrations of 200, 250, and 300 (uM. The other 
important kinetic parameter that was calculated for GDP-mannose 4,6-dehydratase was 
Vmax. The Vmax calculated from these experiments was 0.102+0.008 /zmoles/min.
5 3  Feedback Inhibition of GDP-mannose 4,6-dehydratase by GDP-fucose
GDP-fiicose was the first compound tested as a potential inhibitor for GDP- 
mannose 4,6-dehydratase. GDP-fucose has previously been reported to inhibit this 
enzyme and was therefore chosen as the first molecule to study in this research.3 4 The 
inhibition constant (K i)  determined for GDP-fucose was 95.4+1.85 //M. GDP-fucose is 
the final product of this enzyme pathway and this inhibition is referred to as feedback 
inhibition. When the concentration of the final product builds up to a certain level, 
often it can signal the enzyme to “turn off’ the pathway thus stopping production of the 
product. This is the case with GDP-fucose and the GDP-mannose 4.6-dehydratase 
enzyme. The Lineweaver-Burk plot is shown in for the GDP-mannose 4.6-dehydratase 
enzyme reaction with added amounts of GDP-fiicose. The concentrations of GDP- 
fiicose tested in these experiments was 250, 1000, and 5000 /zM. It can be seen in 
Figure 5.2 that the y-intercept is not changing indicating that this inhibition is
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Figure 5J. Lineweaver-Burk Plot for GDP-fiicose inhibition of GDP- 
mannose 4,6-dehydratase
competitive. The kinetic data for GDP-mannose 4,6-dehydratase with GDP-fucose as 
an inhibitor is summarized in Table S. 1 below.
Table 5.1 Kinetic Data for GDP-mannose 4,6-dehydratase with GDP-fucose as 
an Inhibitor.
GDP-Fucose GDP-fucose GDP-fiicose GDP-fucose
Concentration Average 250/tM 1000 pM. 5000 pM
Vmax
(min/mnol)
0.101810.0003 0.10192+0.0005 0.10146+0.0004 0.10203+0.0010
Ki
{pM)
95.411.85 93.6+1.65 97.3+0.986 95.3± 1.43
R2
0.9943 0.9827 0.9856
5.4 GDP and Fucose Inhibition of GDP-mannose 4,6-dehydratase
Because of the inhibitory activity exhibited by GDP-fiicose, the two molecular 
moieties that make up this molecule, GDP and fucose, were studied to determine if 
these molecules demonstrated any inhibitory activity. These two molecules were found 
to have approximately the same activity with Ki values of 397 fjM. for GDP and 475 //M
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for fucose. It believed that for this enzyme there are two separate binding sites for the 
sugar moiety and the nucleotide moiety. This may explain why the K, value for these 
two molecules is similar. These molecules also exhibited competitive inhibition as 
indicated in the Lineweaver-Burk plots for these two molecules. This data is 
summarized in Tables 5.2-5.3.
Table 5.2 Kinetic Data for GDP-mannose 4,6-dehydratase with GDP as an 
Inhibitor.
GDP GDP GDP GDP
Concentration Average 250 uM 1000 uM 5000 uM
Vmax 0.10181 0.10201 0.10102 0.10241
(min/jtmol) ±0.00071 ±0.00057 +0.00083 +0.00062




Table S 3  Kinetic Data for GDP-mannose 4,6-dehydratase with fucose as an 
Inhibitor.
Fucose Fucose Fucose Fucose
Concentration Average 250 uM iooo m 5000 jiM
Vmax 0.10149 0.10127 0.10153 0.10168
(min/iimol) ±0.00021 ±0-00015 ±0.00027 ±0.00029




S 3  1-deoxynojirimycin, 1-deoxymannojirimycin, and 1-deoxyfuconojirimycin 
Inhibition of GDP-mannose 4,6-dehydratase
The next series of compounds that were selected for testing against the GDP- 
mannose 4,6-dehydratase enzyme was the deoxynojirimycin series. The structures of
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Figure 5 3  Structures of potential inhibitor molecules
these compounds are shown in Figure 5.3. These molecules mimic the structure of 
monosaccharides that have a nitrogen atom in the sugar ring instead of the oxygen atom
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and also the hydroxyl group in the one position of the sugar ring has been removed. 
These molecules were selected due to their structural similarities to the 
monosaccharides yet also in part due to their differences in structures. These molecules 
are known enzyme inhibitors and this was another reason for their selection. For 
example, 1 -deoxymannojirimycin inhibits the o-mannosidase I enzyme which is 
responsible for cleaving mannose residues from oligosaccharide chains.s Of this set of 
molecules, 1-deoxyfuconojirimycin was the best inhibitor with a K, value of 337+12.8 
fdM. As shown in Figure 5.3, this molecule is a modified monosaccharide with basic 
structure of fucose with a nitrogen atom substituted in the sugar ring and the hydroxyl 
group in the one position missing. The other two remaining compounds in this structure 
series were not as successful as 1-deoxyfuconojirimycin at inhibiting GDP-mannose
4.6-dehydratase, but they did show some activity toward the enzyme. 1- 
deoxymannojirimycin was found to have a Ki value of 991+18.2 /uM and l- 
deoxynojirimycin was found not to be as effective with a K, value of 1503+14.1 //M. 
Each of these molecules also exhibited competitive inhibition toward the GDP-mannose
4.6-dehydratase enzyme. The kinetic data for these molecules is summarized in Tables 
5.4-5.6.
5.6 Other Potential Inhibitor Molecules for GDP-mannose 4,6-dehydratase
Several other molecules were tested as potential molecules, but were found to have 
no effect on the GDP-mannose 4.6-dehydratase enzyme even at inhibitor concentrations 
as high as 5 mM. These molecules include the sugar nucleotides ADP-Ribose, UDP-
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Table 5.4 Kinetic Data for GDP-mannose 4,6-dehydratase with 





























Table 5.5 Kinetic Data for GDP-mannose 4,6-dehydratase with 




























Table 5.6 Kinetic Data for GDP-mannose 4,6-dehydratase with 
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galactose, UDP-glucose, and also tunicamycin, which mimics the structure of sugar 
nucleotides only to have the diphosphate linkage replaced with a methylene group. 
These molecules were determined not to have an effect on the enzyme studied if no 
inhibition was shown at an inhibitor concentration of 5 mM. Several reasons exist why 
these molecules don’t show any inhibition. The nucleotide portion of UDP-galactose 
and UDP-glucose are made up a pyridimdine base, which is different from GDP- 
mannose and GDP-fucose consisting of a purine base. This may account for one reason 
why the UDP-sugar nucleotides do not show any activity to this enzyme. Secondly, the 
sugar portion of these molecules is different from either the fucose or mannose structure 
that this enzyme is programmed to recognize.
As stated before, the tunicamycin molecule that was tested for an inhibitory effect 
has a structure different from any of these molecules. This molecule consists of a 
pseudo nucleotide base and the diphosphate linkage of sugar nucleotides is mimicked 
by a methylene linkage. This basic structure is then completed by a sugar moiety on 
one end of the molecule with an aliphatic hydrocarbon chain on the other. This 
molecule is a known inhibitor of oligosaccharide addition to growing proteins.6 7 The 
motivation for testing this molecule as an inhibitor in this work was the fact that its 
structure mimicked that of a sugar nucleotide. One thought as to why this molecule was 
not effective as an inhibitor is the fact that the molecule is larger than the GDP-mannose 
or GDP-fiicose molecules used in this enzyme reaction. The tunicamycin may not have 
been able to access the active site of the enzyme to bind efficiently enough to hinder the 
enzyme activity. The important interactions such as hydrogen binding/donation used to
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hold the substrate molecule in place may simply not have been accessible to this large 
molecule.
5.7 Possible Active Site Composition
Several groups have speculated as to what amino acid residues make up this active 
site as well as what the mechanism of catalysis could be.8 One idea is that the active 
site resembles that of the UDP-galactose 4-epimerase, which is a member of the short 
chain dehydrogenase/reductase family of enzymes to which GDP-mannose 4.6- 
dehydratase is thought to belong. UDP-galactose 4-epimerase is well characterized both 
















Figure 5.4 Proposed mechanism for catalysis in GDP-mannose 4,6- 
dehydratase
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Figure SS  A second proposed mechanism for the catalysis of GDP-mannose
4,6-dehydratase
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the amino acid level with GDP-mannose 4,6-dehydratase enzyme.9'10 In both enzymes, 
a cofactor is reduced and then oxidized in the course of the enzyme reaction. NAD is 
the cofactor for UDP-galactose 4-epimerase and NADP plays the same role in GDP- 
mannose 4,6-dehydratase. Both of these enzymes are believed to involve an
intramolecular hydride shift of a hydride that is removed horn the sugar molecule and 
then transferred to another part of that same molecule. The difference in these two 
molecules is that the hydride removed from the C-4 in the UDP-galactose 4-epimerase 
is later returned to the C-4 position while in GDP-mannose 4,6-dehydratase, the hydride 
is removed from C-4 and returned to C-6. Based on the similarities in amino acid 
sequence of the enzymes as well as the reaction mechanisms it has been postulated that 
the residues involved in the active site may be conserved as well. Another similar 
enzyme to the GDP-mannose 4,6-dehydratase enzyme is the CDP-glucose 4.6- 
dehydratase. This enzyme has been shown to bind the substrate as well as the reduced 
from of the cofactor just as GDP-mannose 4,6-dehydratase.11
This GDP-mannose 4,6-dehydratase enzyme is thought to exist as a dimer in 
solution that is capable of binding two molecules of GDP-mannose substrate as well as 
two molecules of the NADPH cofactor.3 This is also true of the UDP-galactose 4- 
epimerase. Both of these enzymes therefore have the potential of having two 
catalytically active sites per dimer. Many highly conserved residues throughout the 
species that produce the GDP-mannose 4,6-dehydratase are thought to be involved in 
the cofactor binding as well catalysis. These residues include Hisl87, Argl92, Asnl86, 
Glul35, Phel96, Asp 14, Lysl61, Tyrl57, and Ser90. Specifically, Tyrl57 and LysI61 
are part of a serine, tyrosine, and lysine triad of residues that are conserved across this
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family of enzymes and play a part in cofactor binding and catalysis.12 The tyrosine 
hydroxyl group can hydrogen bond to one of the ribose hydroxyls and the amino group 
from the lysine appears to interact with both two hydroxyl groups of the ribose. For 
most enzymes in this family, the third residue in this conserved catalytic triad is a 
serine, but in E. coli GDP-mannose 4,6-dehydratase Thrl33 replaces this residue. 
Another set of conserved residues believed to bind the sugar moiety of the substrate 
exist in each of the species which produce GDP-mannose 4,6-dehydratase. These 
residues are Asnl86, Ser 134, Glul35, Leu320, and Ser90. From the proposed 
mechanisms of catalysis discussed above and shown in Figures 5.4 and 5.5. two basic 
residues must be present near the sugar moiety for that catalysis to occur it is believed 
that these two residues could be included in the list of conserved residues.
5.8 Possible Methods of Catalysis for GDP-mannose 4,6-dehydratase
Enzymes with similar amino acid sequence and structure as GDP-mannose 4.6- 
dehydratase have been studied and it believed that GDP-mannose 4.6-dehydratase 
proceeds through the same mechanism as these enzymes.8 From the data presented for 
the stereochemistry of these other enzymes reactions involving this same type of 
mechanism, an intramolecular hydrogen migration of H-4 to C-6 is thought to occur. 
This implies that the transfer of H-4 to C-6 must be suprafacial.8 In order for this shift 
to occur, the cofactor (NADPH) must be situated on the face of the sugar ring where H- 
4 is in the axial position. Two basic groups from the enzyme active site assist in this 
reaction. The substrate molecule is situated in the active site such that one of the basic 
groups is in the proximity to the hydroxyl group on C-4 of the sugar ring and the other 
is near the hydrogen on C-5 and the hydroxyl group on C-6. Two possible mechanisms
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of catalysis have been proposed for the GDP-mannose 4,6-dehydratase enzyme. The 
first mechanism is one that resembles that of dehydroquinate dehydratase and is shown 
in Figure 5.4. After dehydrogenation at C-4, the mechanism shown in Figure 5.4 
envisions a syn elimination of water between C-5 and C-6. This is followed by hydride 
reduction of the polarized C-C double bond. The second proposed mechanism shown in 
Figure 5.5. This mechanism involves enolization of the 4-keto group with proton 
transfer from C-5 to the hydroxyl group on C-6. This is followed by a concerted 
displacement at C-6.
5.9 Explanation for Inhibitor Molecules of Action
Of all the potential molecules tested, the ones that exhibited inhibition are
summarized in Table 5.7. Each of these molecules acted as competitive inhibitors
Table 5.7 Summary of Kj Values Calculated for Inhibitor Molecules







meaning they all competed with the substrate for binding in the active site of the 
enzyme. The most effective inhibitor found during this research project was GDP- 
fucose, which is the final product of the enzyme pathway, and therefore this is feedback 
inhibition. GDP-fucose shares the same nucleotide base as GDP-mannose and this may
be the explanation for the tight binding of this molecule into the active site of the GDP-
mannose 4,6-dehydratase and thus, the inhibitory effect of GDP-fucose. When the
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constituent molecular moieties of this molecule were tested, it was found that GDP as 
well as fucose exhibited some inhibition of GDP-mannose 4,6-dehydratase. This 
indicates that each of these molecules also binds in the active site of the enzyme. This 
led us to test more monosaccharide like molecules such as the 1-deoxynojirimycin 
series of compounds. As stated earlier these molecules resemble that of
monosaccharides with two main changes in the structure. The one position of these 
molecules has been dehydroxylated and the inhibitory effect is still present. This 
indicates that the GDP moiety in the one position of the sugar ring in not necessary for 
inhibition of this enzyme. These molecules are much smaller than the GDP-mannose 
sugar nucleotide and therefore may be capable of binding in the active site, perhaps in a 
different region than the catalysis center, therefore blocking the GDP-mannose from 
occupying the active site and beginning the enzyme reaction. The 1-
deoxyfuconojirimyin was the most effective of this series of molecules indicating that
the fucose moiety is important in binding into the active site and hindering enzyme 
activity. The l-deoxymannojirimyicn was marginally more effective than l-
dexoynojrimycin at inhibiting this enzyme reaction indicating that these modified 
monosaccharides are important as inhibitors regardless of the sugar confirmation.
5.10 Conclusions
Kinetic studies were performed to examine the reaction rates of GDP-mannose
4,6-dehydratase with and without potential inhibitor molecules. The results of these 
inhibitor studies have been summarized in Table 5.7. GDP-fucose was found to be the 
most effective inhibitor for this enzyme of all the molecules tested in this research 
project. Other molecules found to act as inhibitors of GDP-mannose 4.6-dehydratase
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include GDP, fucose, 1-deoxyfuconojirimycin, 1-mannojirimycin, and 1-
deoxynojirimycin. The fucose structure moiety has been indicated to be important in 
the structure of an inhibitor for this enzyme. Of the molecules tested, each molecule 
that contained this structure moiety was found to be active against this enzyme.
5.11 References
1. Rawn, D.; Biochemistry; Neil Patterson Publishers; Burlington; 1989.
2. Palmer, T. Understanding Enzymes', Ellis Horwood Limited; Chichester: 1985.
3. Sullivan, F,; Kumar, R.; Kriz, R.; Stahl, M.; Xu, G.; Rouse, J.; Chang, X.; Boodhoo. 
A.; Potvin, B.; Cumming, D. The Journal of Biological Chemistry, 1998, 273, 8193- 
8202.
4. Sturla, L.; Bisso, A.; Zanardi, D.; Benatti, U.; De Flora, A.; Tonetti, M. FEBS 
Utters, 1997,412, 126-130.
5. Stutz, G.; Iminosugars as Glycosidase Inhibitors Nojirimycin and Beyond; Wiley- 
VCH; New York; 1999.
6. Zubay, G.; Biochemistry', Wm. C. Brown Publishers: Boston, 1998
7. Varki, A.; Cummings, R.; Esko, J.; Freeze, H.; Hart, G.; Marth, J. Essentials of 
Glycobiology; Cold Spring Harbor Laboratory Press: Cold Spring Harbor, 1999.
8. Oths, P.; Mayer, R.; Floss, H. Carbohydrate Research, 1990,198, 91-100.
9. Thoden, J.; Frey, P.; Holden, H. Biochemistry, 1996,35, 2557-2566.
10. Thoden, J.; Frey, P.; Holden, H. Biochemistry, 1996, 35, 5137-5144.
11. Yu, Y.; Russell, R.; Thorson, J.; Liu, L.; Liu, H. Journal o f Biological Chemistry. 
1992,267, 5868-5875.
12. Somoza, J.; Menon, S.; Schmidt, H.; Joseph-McCarthy, D.; Dessen, A.; Stahl, M.: 
Somers, W.; Sullivan, F. Structure, 2000,8, 123-135.
76
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
C hapter 6 
Conclusions and F u tu re Studies
6.1 Summary of Conclusions
This research project has concerned the investigation of potential inhibitors for the 
GDP-mannose 4,6-dehydratase enzyme. Several steps were taken in this research 
project before these inhibition studies could be initiated. The first phase of this work 
was to express and purify the enzyme to be used in this research. As described in 
Chapter 3, plasmid DNA for the GDP-mannose 4,6-dehydratase enzyme was received 
from Genetics Institute. This DNA was transformed into E. coli, which were used to 
synthesize the enzyme followed by a multi-step purification scheme. After this 
purification scheme, the obtained protein was analyzed for enzyme activity. Before the 
enzyme could be analyzed properly, an HPLC method had to be developed in order to 
efficiently separate the guanosine sugar nucleotide analytes that resulted from the 
enzyme assays. The method that was developed employs an isocratic mobile phase 
which consists of a 0.5 M phosphate buffer, a Nucleosil octadecyl column, and LTV 
detection at 254 nm. The described method is effective at the separation of guanosine 
nucleotides and sugar nucleotides, which was previously undescribed in the literature. 
This method is applicable to a variety of reaction schemes and is therefore useful to 
other researchers not only those studying this enzyme sequence. Once a method of 
analysis was established for the enzyme reaction products, the kinetic studies of this 
enzyme were initiated. The kinetic parameters for GDP-mannose 4,6-dehydratase were 
established before the inhibitor studies were begun. The Km value for this enzyme was 
established to be 283.3+12.3 /|M while the Vmax value to be 0.102+0.0008 /iM/min.
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Several potential inhibitor compounds were tested using standard assay conditions as 
well as the HPLC method developed earlier in this work. The most effective inhibitor 
that found in this work was GDP-fucose with a Ki value of 95.4±1.85 /iM. Because 
GDP-fucose is the final product for this enzyme system, inhibition by this molecule is 
referred to as feedback inhibition. The second most effective inhibitor found was 1- 
deoxyfuconojirimycin with a Ki value of 337.9+12.8 /tM. GDP and fucose were the 
next most effective inhibitors of the molecules tested. The Ki values for these 
molecules were 396.7+10.7 and 465.9+9.53 /xM respectively. Two other molecules 
also exhibited an inhibitory effect on the GDP-mannose 4,6-dehydratase enzyme. 
These molecules were 1-deoxymannojirimycin and 1-doexynojirimycin. Of the 
molecules that did exhibit an effect on this enzyme, these molecules were the least 
effective with Ki values of 991+18.2 /lM for 1 -deoxymannojirmiycin and 1503+14.0 
fjM for 1-deoxynojirmycin. An important trend was established in the structure of the 
inhibitor molecules. Ail of the molecules tested that contained the fucose structure 
moiety exhibited an inhibitory effect against the GDP-mannose 4.6-dehydratase 
enzyme. Several molecules were tested that didn’t have an effect on the enzyme system 
even at inhibitor concentrations of 5mM. These included UDP-glucose. UDP- 
galactose, ADP-ribose and tunicamycin. The lack of inhibition by these molecules 
gives more insight into what structural features are important in designing an inhibitor 
for GDP-mannose 4,6-dehydratase enzyme. From this research it may be concluded 
that the purine base is required for a nucleotide analog to be effective because the 
pyridimdine base of the UDP nucleotides didn’t seem to have an effect on the enzyme.
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6.2 Summary of Observations Supporting Conclusions
The first step in this research project as stated above was to transfect bacteria cells 
with the plasmid DNA received from Genetics Institute. This was demonstrated by 
agarose gel electrophoresis analyses performed on plasmid DNA isolated from E. coli 
cells that had been transfected with the plasmid DNA. Agarose gel electrophoresis 
analyses indicated that the plasmid DNA from transfected cells was the same size as the 
original plasmid DNA received from Genetics Institute. After this was confirmed, a 
restriction enzyme digest was performed and the analysis of this digest showed that the 
resulting fragments of DNA were the same size as predicted and also the size as 
fragments that resulted from the digestion of the original plasmid DNA.
After incorporation of the plasmid DNA into the E. coli ceils, the bacteria were 
used to produce the enzyme for use in the inhibition assays. This enzyme had to be 
purified from other proteins in the bacteria cells as shown in PAGE gel images. The 
molecular weight of the GDP-mannose 4,6-dehydratase is approximately 40 kD. These 
gels were used to determine the molecular weight of the proteins that were eluted off 
the ion-exchange purification columns and indicated that the molecular weight of the 
protein that was over-expressed had a molecular weight of 40 kD. Also, an activity 
assay was conducted to determine if the fractions with the correct molecular weight 
were capable of catalyzing the conversion of GDP-mannose into GDP-4-keto-6- 
deoxymannose. The fractions of proteins that did catalyze this reaction were 
determined to be purified GDP-mannose 4,6-dehydratase.
The next step in this project was to develop an HPLC method to analyze the 
enzyme reactions that were performed. A method to separate these guanosine sugar
79
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
nucleotides and guanosine nucleotides was successfully created using an isocratic 
mobile phase of O.S M phosphate buffer pH 6.2 and a Nucleosil octadecyl column. The 
detection mode employed was UV absorption at 254 nm. The results of using these 
separation conditions can be seen in several chromatograms that show baseline 
resolution of the GDP, GMP, and GDP-mannose standards that were used in the 
development of this method. A study using the purified GDP-mannose 4,6-dehdyratase 
enzyme illustrated that this method could be employed in analyzing this enzyme 
reaction. The compiled chromatogram shows that over the time the GDP-mannose 
substrate disappears while the GDP-mannose-4-keto-6-deoxymannose product appears. 
This is the method that was utilized in the inhibition studies.
The fourth conclusion that was drawn in this work was kinetic parameters for 
this purified GDP-mannose 4,6-dehydratase. Several assays were conducted to 
determine the kinetic parameters for this enzyme such as Km and Vmax. The Km for 
this enzyme was determined to be 280+12.3 fiM. and the Vmax was determined to be
0.102+ 0.0008 ^M/min. These parameters were calculated from the x- and y- intercepts 
in the Lineweaver-Burk plots constructed from data collected for these reactions.
After the kinetic parameters were defined for the enzyme, small molecules were 
added to the enzyme reaction mixture one by one to determine the effect of each 
molecule on the system. GDP-fucose was the first potential inhibitor tested. This 
molecule was found to have a Ki value of 95.4+1.85 /zM. This inhibition constant was 
calculated from the Lineweaver-Burk plot constructed for this new enzyme reaction 
system and the x- and y-intercepts. Next, the structural moieties that make up GDP- 
fucose were tested to determine how these molecules effected this reaction. GDP was
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found to have a Ki value of 396.7+10.7 /zM and fucose was found to have a K, value of 
465.9+9.53 fjM. After testing these two molecules, the 1-doexynojirimycin series of 
compounds was tested against the GDP-mannose 4,6-dehydratase. The most effective 
compound as an inhibitor in this series was I-deoxyfuconojirimycin with a K, value of 
337.9±12.8 fJM. Two other compounds with this similar structure were also tested. 
These compounds were 1-deoxymannojirimicin and 1-deoxyfuconijirimycin. Neither 
of these compounds proved as effective as 1-deoxyfuconojirimycin. These observations 
support the conclusion that the fucose structure moiety seems to be very important in a 
potential inhibitor molecule. When fucose was incorporated into the structure of the 
potential inhibitor molecule, an inhibitory effect was observed for that molecule.
Several other molecules were tested as potential inhibitors in this research. 
These molecules included UDP-glucose, UDP-galactose, ADP-ribose, and tunicamycin. 
Even at inhibitor concentrations of 5 mM, these molecules did not exhibit any effect on 
this enzyme system. This observation that these molecules did not have a detectable 
effect on this enzyme system helped lead to the conclusion that the structure of these 
molecules were not necessary for inhibition of this enzyme. This observation also 
supports the conclusion that the fucose structure moiety is important in the design of an 
inhibitor for this enzyme system.
6 3  Future studies
Many future directions can be envisioned for this research project. One important 
direction is to purse the indication that the fucose moiety is important in the structure of 
a potential inhibitor. A beginning point to study this theory is the derivatization of 
fucose with different functional groups. An example of this may be to derivatize fucose
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with an acetyl group in order to make the molecule more bulky. A second purpose to 
this derivatization would be to remove the hydrogen bond donors from the sugar ring 
and increase the number of hydrogen bond acceptors. This tactic could be used to 
further investigate the active site composition of this enzyme to determine which types 
of moieties would bind into this active site and inhibit enzyme activity. Other 
derivatizations of fucose may also be useful in investigating the active site. For 
example, derivatizing the hydroxyl groups with alkyl chains of varying length can give 
information such about the size of the active site pocket. Derivatives of GDP-fucose 
may also be synthesized just as the derivatives of fucose itself are made. GDP-fucose is 
a better inhibitor of this enzyme than fucose therefore the derivatives of GDP-fucose 
may strengthen the binding of the inhibitor to the enzyme thus creating a more effective 
inhibitor. From the information gained by studying derivatized fucose and GDP-fucose 
molecules, a clearer understanding of the active site may lead to design and synthesis of 
an inhibitor that could be useful as a pharmaceutical.
A second type of compound to test would be to synthesize a derivative of the GDP- 
fucose. An example would be the difluoro derivative resembling that of CDP-6-deoxy- 
6, 6-difluoroglucose derivative which was synthesized by Chang et a/.1 This molecule 
has been demonstrated to inhibit the CDP-glucose 4,6-dehydratase enzyme that acts in 
the same manner as GDP-mannose 4,6-dehydratase. This derivative was reported to 
have a Ki value of 940 (iM that is close to that of l-deoxymannojirimycin for the GDP- 
mannose 4,6-dehydratase enzyme. The same derivative for GDP-fucose could be 
synthesized and examined against the enzyme studied in this work.
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A third direction for this work would be to synthesize a sugar nucleotide analog 
using the GDP nucleotide and 1 -deoxyfuconojirimycin molecules. This molecule 
should be effective at inhibiting this enzyme because it will include the fucose moiety 
as well as the GDP moiety. Both these molecules have been screened in this work and 
have been shown to have an inhibitory effect on the enzyme. It has also been 
speculated that these molecules have separate binding regions within the active site. By 
uniting these two structural features, a tight binding inhibitor should result.
Also one aspect of this research that may be reexamined in a future study is the 
enzyme assay conditions. The conditions that were used in this research are those 
described by Sullivan et al. in their work with the GDP-mannose 4.6-dehydratase 
enzyme.2 Upon examination of the literature, a divalent cation may change the kinetics 
of the GDP-mannose 4,6-dehydratase enzyme reaction. In work described by Tonetti et 
al., magnesium chloride was included in the assay mixture.3 The Km value noted for 
GDP-mannose 4,6-dehydratase with ImM MgCl2 included in the assay mixture was 
222+44 /iM compared to the Km 280 + 12.3 found in this work without the divalent 
cation present. Metal cations have been shown to help in the orientation of enzyme- 
substrate-metal ion complexes formed by kinase enzymes such as creatine kinase.4 
These metal ions may also assist in the breaking of the pyrophosphate bonds by drawing 
electrons away form the ^-phosphate groups in the action of the kinase enzymes which 
is to phosphorylate molecules. In contrast to the creatine kinase, the metal cations have 
also been shown to form an enzyme-metal-substrate bridge. In this instance, the metal 
cation exhibits a strictly structural role. The work presented here and by other authors, 
does not describe the effect of the metal cation on the dehydratase enzyme. Also other
83
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
enzyme that have structural similarities to GDP-mannose 4,6-dehydratase enzyme have 
not been studied with the metal cations to determine the effect of them on this class of 
enzymes. By adding the metal cations, either calcium or magnesium, to the enzyme 
reaction mixture, it may be determined that these ions do increase the catalytic rate of 
this enzyme as preliminarily indicated by Tonetti’s work.
Recently the crystal structure of the GDP-mannose 4,6-dehydratase enzyme has 
been solved.3 This paper examines the binding of the substrate and cofactors in the 
active site of the enzyme. Its has been shown that the nucleotide and the sugar moiety 
of the nucleotide substrate bind in two separate sites on the enzyme. This has also been 
illustrated in the work described in this dissertation. It was also shown that NADPH is 
the preferred cofactor in this enzyme as shown by several other researchers and 
discussed previously. Site directed mutagenesis was used by these researchers to 
determine the role do the active site catalytic residues. These residues include Thrl33. 
Glul35, Tyrl57, and Lysl61. With the knowledge that these residues are in the active 
site, a more effective inhibitor molecule may be designed for this enzyme system.
Another direction for this project would be to begin study of the second enzyme 
in the pathway that is responsible for the synthesis of GDP-fucose. This is enzyme is 
the epimerase/reductase which follows the GDP-mannose 4,6-dehydratase enzyme. 
This enzyme then uses the GDP-4-keto-6-deoxymannose as the substrate and coverts it 
into GDP-fucose through first an epimerization followed by a reduction. Some of the 
inhibitors found for GDP-mannose 4,6-dehydratase found in this work should be screen 
against this second enzyme because the binding sites may be similar in the two enzyme 
due to the fact that the molecules binding in these sites are very similar in structure.
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The research conducted in this project is just the beginning of studying the 
inhibition of GDP-mannose 4,6-dehydratase. From the results obtained in the work 
described in this document, many avenues have been opened to explore in an attempt to 
improve on the inhibitor molecules found in this work.
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